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Pincer-crown ether ligands were designed to exhibit hemilability and also support cation- 
macrocycle interactions. These ligands feature strong phosphine and phenyl donors, and a 
pendent aza-crown ether group that provides hemilabile donors that can bind to the transition 
metal center and serve as a docking site for cations. Cation-macrocycle interactions can be 
exploited to directly control the primary coordination sphere of these complexes leading to 
control over ligand substitution reactions and catalysis. When the macrocycle acts simply as a 
docking site for cations, bound cation-substrate interactions can be harnessed to modulate 
reactivity.  
In chapter 2, nickel catalysts supported by diethylamine- or aza-crown ether-containing 
aminophosphinite (NCOP) pincer ligands catalyze the insertion of benzaldehyde into a C−H 
bond of acetonitrile. Neutral tert-butoxide precatalysts are active without any added base and 
give good yields of product after 24 h, while the cationic precatalysts require a base cocatalyst 
and operate much more slowly. In situ spectroscopic studies identified several intermediates and 
a common deactivated species. The deactivated cationic species is inactive under standard base-
free conditions, but catalysis can be reinitiated by the addition of base. 
 In Chapter 3, the thermochemistry of cation−macrocycle interactions in nickel pincer 
complexes bearing a hemilabile aza-15-crown-5 or aza-18-crown-6 macrocycle is investigated 
 iv 
and applied to cation-controlled reversible ligand binding. Cation−crown interactions were 
examined in the solid-state and in solution (dichloromethane, and acetonitrile). Tridentate-bound 
pincer complexes bind cations more than 100,000 times more strongly than the tetradentate 
counterparts with a crown ether oxygen donating to nickel. The newfound thermodynamic 
insight guided the development of in situ switchable ligand binding and release at nickel using 
cations.  
 In Chapter 4, the impact of post-macrocyclization modification of 1-aza-15-crown 5 
through synthetic organic and organometallic tuning is discussed. Binding affinities for Li+ and 
Na+ salts are reduced substantially moving from the simple organic macrocycle to an 
organometallic pincer-crown ether. The selectivity for Li+ over Na+ increases dramatically, by as 
much as 30-fold. The impact of transition metal and ligand substitution at the metal center 
significantly impacts Li+ binding strength. Preliminary heteroditopic binding of LiCl by an 
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CHAPTER 1: INTRODUCTION 
 
1.1 Controllable Catalysts 
 
 Catalysts play a vital role in biology and in the chemical and pharmaceutical industries by 
providing efficient, low-energy pathways for selectively breaking and making chemical bonds. 
In biology, enzymes catalyze a wide variety of complex biochemical reactions that are vital to 
our lives.1-2 In the chemical and pharmaceutical industries, synthetic catalysts have been 
employed successfully for over 100 years. They have enabled breakthrough discoveries in 
chemical synthesis and have lowered the energy needed to operate critical processes on large 
scales, providing molecular building blocks and chemical compounds that save lives and help 
continue to increase the standard of living worldwide.3 Over 75% of chemicals from industry are 
produced with the aid of catalysts.4 Catalyst development and improvement paves the way for 
the discovery of new chemicals, improves the energy efficiency of industrial processes, and aids 
in the avoidance of the generation of toxic by-products, maximizing social and economic 
benefits while minimizing negative environmental impacts.3-4 
One class of catalysts that is particularly promising both practically and fundamentally is 
in situ controllable catalysts. A controllable catalyst is one that exhibits a change in activity or 
selectivity upon in situ exposure to an external stimulus or a change in experimental conditions.5-
6 Regulating the behavior of catalysts in situ can give these molecules unique properties such as 
the capability for on/off switchability, stimuli-induced rate tuning, and stimuli-induced changes 
in reaction specificity or selectivity, all without the need for synthetic modifications to the 
catalyst itself. Additionally, the ability to trigger or modify the rate of a reaction with an external 
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stimulus allows for temporal control over chemical reactions, a property generally only 
associated with complex biocatalysts.5-6 
Controllable catalysts could find use in a wide array of applications, especially the 
growing field of tandem catalysis.7-11 For example, tunable catalysts could be optimized to be 
kinetically compatible with other processes occurring in a chemical reaction. Switchable 
catalysts could be switched on to complete a portion of the tandem catalysis and then switched 
off to a protected state until needed again or until recovery occurs. Controllable catalysts that 
alter selectivity could be used to generate specific regioisomers or stereoisomers of products 
based on the stimulus added. Eventually controllable catalysts could be designed to synthesize a 
variety of different products from a pool of building blocks simply by varying the order and type 
of stimuli applied. Two promising ways to control catalyst reactivity using this approach rely on 
controlling substrate binding to the catalyst active site and controlling substrate activation 
through secondary interactions with an added stimulus. 
1.2 Controlling Catalysis by Gating Substrate Binding 
 
 Enzymes catalyze a plethora of biochemical reactions in nature through complex 
metabolic pathways. These pathways generally consist of several different enzymes that work in 
concert to form a single product.12 In order to control the amount of product produced by these 
pathways, many enzymes use allosteric regulation. Allosteric regulation uses the binding of 
specific cofactors at an allosteric site (a site other than the catalytically active site) to trigger a 
change in conformation that directly affects the enzyme’s ability to catalyze a given reaction.12 
Upon exposure to the allosteric regulator, these enzymes shift between structures that have 
unique properties such as increased substrate affinity or properly positioned catalytic side chains 
that directly impact catalytic rates.12 
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There are several modes of action by which allosteric regulation modulates enzyme 
affinity for a substrate. In some enzymes, access to the active site is physically blocked in the 
inactive state. A cofactor interacts with the allosteric site of the enzyme and triggers a change in 
confirmation that unblocks the active site and allows substrate access and catalysis to occur.12 
Such a pathway is proposed in human isocitrate dehydrogenase, which oxidatively 
decarboxylates isocitrate to a-ketoglutarate.13 Allosteric regulation is achieved through binding 
of magnesium adenosine diphosphate (ADP) and citrate to an allosteric portion of the enzyme. 
This triggers a significant structural rearrangement facilitating isocitrate access to the enzyme 
active site and catalytic turnover (Figure 1.1).13  
 
 
Figure 1.1 Native structure of human isocitrate dehydrogenase before and after citrate and 
MgADP binding; the major changes are surrounding Tyr126 (green) and Asp230 (blue) residues. 
 
 Beyond enzymes, artificial allosteric regulation has been achieved using large 
supramolecular assemblies that undergo structural changes upon addition of an external 
stimulus.14 These synthetic constructs operate in a manner analogous to many enzymes, with 
large groups physically block the catalyst active site preventing substrate access and catalytic 
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turnover. Addition of an allosteric regulator, for example ions, small molecules, or other ligands, 
triggers a structural rearrangement that unblocks the active site and allows substrate access and 
catalytic turnover.  
Mirkin and co-workers have developed sophisticated supramolecular systems based on 
the “Weak Link Approach” that can be allosterically regulated by chloride and carbon 
monoxide.15-17 In these systems, the allosteric regulators trigger structural reorganization through 
coordination to a transition metal center in part of the supramolecular scaffold.15 In Scheme 1.1, 
a triple-layer catalyst for the switchable polymerization of e-caprolactone is depicted.18 Two 
square planar rhodium(I) subunits containing phosphinoamine ligands with large biaryl blocking 
groups flank an aluminum catalyst and prevent substrate access. Addition of chloride results in 
displacement of the amine ligands from the rhodium centers unblocking the aluminum active site 
and triggering catalysis.  
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Scheme 1.1 Supramolecular allosteric regulation via the Weak Link Approach. Blocking groups 
disrupt substrate access to the Al active site. Chloride displaces the amine donors tethered to the 
large blocking groups to enable catalysis.  
 
Supramolecular machines have also been shown to control catalysis harnessing a similar 
conformational gating or blocking approach. A molecular rotor with catalyst subunits installed 
remotely as end groups was reported as a switchable catalyst for Michael addition reactions. The 
photo- and thermo-isomerizable assembly could be rotated upon light or heat exposure to control 
both activity and selectivity of the reactions.19 Rotaxanes have also shown promise as 
controllable catalysts, with macrocycles as reversible blocking groups, shuttling back and forth 
depending on protonation states to reveal and conceal active sites.5, 20 Supramolecular cages21-25 
and polymer networks26-28 offer control of the environment around the catalyst and can regulate 












































In situ control over substrate binding and catalysis in small organometallic systems is less 
developed, particularly in terms of using post-synthetic modifications and non-covalent 
interactions to control substrate binding and catalysis.29-31 Select systems capable of some degree 
of control over catalysis or ligand substitution are shown in Figure 1.2. In situ modification of a 
ligand by changing pH to reach different protonation states with varying reactivity has been 
achieved.32-35 Ligands have also been designed to incorporate receptors for additives such as 
Lewis acids where binding of the Lewis acid to the ligand directly affects the electron donating 
ability of the ligand.36-38 Light- and redox-triggered substitution have also been extensively 
studied.30, 39-44   
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Figure 1.2 Selected strategies for in situ control over reactivity and substitution in small 
organometallic systems. 
 
A major goal of the work described in this thesis was to develop a new way to control 
substrate binding to small organometallic systems. Hemilabile ligands were identified as 
promising candidates for development of controllable catalyst systems. A hemilabile ligand is a 
chelate that contains a strong donor along with a weaker donor capable of reversible 
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identity of the donors and the identity of the linker between the donors and have been shown to 
support optimization using the traditional synthetic approach to catalyst optimization.46-48  
 
 
Figure 1.3 Cartoon depiction of ligand hemilability. 
 
 A number of remarkable catalysts are constructed using ligands with hemilabile oxygen 
donors (Figure 1.4). Highly active Hoveyda-Grubbs-type catalysts feature styrenyl ether ligands 
that impart an extraordinary amount of stability allowing select catalysts to be recovered by 
column chromatography and recycled after olefin metathesis reactions.49-50 Phosphinoamide 
chromium catalysts with hemilabile aryl ether moieties also display increased catalytic 
productivity attributed to an increase in stability imparted by the pendent hemilabile donors.51-53 
Hemilabile, P,O-donor phosphino-ether ligands have been found to be particularly suitable for 
various palladium catalyzed cross-coupling reactions.54-55 These ligands stabilize the highly 
active catalysts while preventing the coordinative saturation problems that generally plague 
phosphine-based catalyst systems. Additionally, N,O-chelate amidate ligands are among the 
most successful catalysts for titanium catalyzed polymerization reactions and hydroamination of 















Figure 1.4 Select catalysts featuring ligands with hemilabile ether oxygen donors. 
 
These ligands impart a unique combination of activity and stability to catalysts that help 
them outperform and outlast catalysts lacking hemilabile motifs. Unlike the preceding examples 
of complexes and catalysts that can be tuned in situ, however, synthetic modifications are 
generally required to alter the properties of this ligand class. These synthetic modifications often 
shift the activity/stability balance of the catalysts unpredictably, highlighting the need for an 
easily modifiable and tunable subclass of these highly useful ligands.57-60 
 In targeting a subclass of tunable hemilabile ligands, inspiration was taken from the rich 
fields of metallomacrocycle chemistry61 and metallacrown ether chemistry.62 These complexes 
incorporate moieties capable of secondary interactions with metal cations or organic guests and 
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supramolecular aggregates,72-74 and bimetallic activation and catalysis.75-85 Often these moieties 
consist of polyethylene glycol-based bridges or crown ethers synthetically incorporated into a 
ligand scaffold that positions guests in the secondary coordination sphere of transition metal 
complexes (Figure 1.5).  
 
 
Figure 1.5 Metallomacrocycles capable of complexing an additional cation in the secondary 
coordination sphere of the complex. 
 
We envisioned a system capable of exploiting this type of secondary interaction to 
exhibit in situ control over ligand substitution and catalysis through tunable hemilability. The 
pincer-crown ether system incorporates an aza-crown ether donor as part of an aminophosphinite 
pincer scaffold featuring strong, anchoring phosphine and phenyl donors (Scheme 1.2).86 The 
oxygen atoms of the aza-crown ether macrocycle can act as weak, hemilabile donors to the metal 






































tetradentate (κ4) configuration, dissociation or displacement of the ether oxygen presents an 
opportunity for ligand substitution. Additionally, upon dissociation or displacement, the pendent 
macrocycle becomes available for secondary, non-covalent interactions with cationic guests. 
These interactions can be harnessed to offset unfavorable ligand substitution using the dual 




Scheme 1.2 Dual equilibrium for tunable hemilability with pincer-crown ether complexes. 
 
Using this approach, a wide variety of simple cationic additives can be used to tune 
ligand substitution and catalysis in situ with pincer-crown ether complexes, all without any 
synthetic modifications to the complexes. The pentadentate-bound Ir hydride complex [k5-
(15c5NCOPiPr)Ir(H)][BArF4] (ArF = 3,5-bis-(trifluoromethyl)phenyl) was shown to undergo alkali 
metal-dependent H2 activation.87 The rate of the reaction could be tuned over two orders of 
magnitude based on the identity and amount of cation present. The same Ir hydride cation also 
catalyzes the isomerization of allylbenzene to β-methylstyrene (Scheme 1.3).88 Catalysis was 
again shown to be modulated by alkali metal cations with lithium giving up to 1000-fold rate 




























Scheme 1.3 Proposed mechanism for the cation-modulated isomerization of allylbenzene with an 
Ir hydride pincer-crown ether complex. 
 
As detailed previously86 as well as in chapter 3, two equilibria govern cation-modulated 
ligand substitution and catalytic activity with pincer-crown ether complexes: 1) 
association/dissociation of the weak ether donor(s) of the ligand and 2) host-guest interactions 
between cationic additives and the pendent macrocycle. It should also be noted that for this 
approach to be successfully applied to reversible, controllable ligand substitution and tunable 
catalysis, kinetic access to the associated and dissociated forms of the ligand must be facile, and 
host-guest interactions should be kinetically rapid and reversible.  
Controlling ligand binding and catalysis using the dual equilibrium approach requires that 
the system meet several thermodynamic criteria as follows and as depicted in the idealized 
potential energy surface shown in Figure 1.6. Firstly, solvent displacement of the hemilabile 
donor must be unfavorable for maximum control. For instance, the binding of a coordinating 
solvent can interfere with hemilability and compete with substrate binding thereby limiting the 
extent of control over ligand substitution and slowing catalysis. Secondly, ligand or substrate 
displacement of the weak donor should be slightly unfavorable. If the ligand/substrate bound 
species is thermodynamically favored, the secondary equilibrium will offer little to no control 








































fully associated form of the catalyst must be weaker than those with the dissociated form. If 
secondary interactions were strong for both associated and dissociated forms of the catalyst, 
thermodynamic stabilization of all species would simply shift the entire energy surface lower.  
 
 
Figure 1.6 Idealized free energy landscape of cation-modulated substrate binding and catalysis. 
 
The first equilibrium in the dual equilibrium approach, the dissociation/association of the 
weak donor(s) of the pincer-crown ether ligand, will vary from catalyst to catalyst based on the 
metal–oxygen bond strength. The second equilibrium, host-guest interactions between cationic 
additives and the pendent macrocycle, will vary based on the identity of the macrocycle and the 
identity and concentration of the additives. A variety of macrocycles can be installed during 
ligand synthesis.  
The true power in this strategy lies in the availability of a wide variety of cationic guests 
that can be used to tune this second equilibrium. Similarly to organic crowns, pincer-crown ether 
complexes of a given ligand are expected to show trends in affinity and selectivity for additives. 
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high level of control over ligand substitution and catalysis. Additionally, a deeper understanding 
these interactions will aid in the development of strategies employing pincer-crown ether 
catalysts and cationic co-catalysts for alteration of product selectivity and bimetallic catalysis via 
substrate activation. 
1.3 Controlling Catalysis Through Substrate Activation 
 
Further applications of pincer-crown ether complexes can be envisioned based on the 
ability of the pendent aza-crown ether moiety to dock cations in close proximity to the metal 
center of the catalyst. Commonly employed alkali metal, alkaline earth, transition metal, and 
lanthanide cations exhibit varying degrees of Lewis acidity. Lewis acids have a rich history of 
promoting a wide array of organic transformations through substrate activation and 
organization.89 These electron pair acceptors form a donor-acceptor complex upon coordination 
to a Lewis basic site on a substrate (Figure 1.8). This complexation results in a partial charge 
transfer to the Lewis acid and a resulting polarization of the donor molecule making it more 
reactive. Lewis acids increase the electrophilicity of carbonyl groups, increase the acidity of 
hydroxy groups, and make coordinated hydroxy, ether, and thioether functionalities better 
leaving groups.89   
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Figure 1.7 General Lewis acid activation of a variety of organic molecules.  
 
Convenient metrics of Lewis acidity include the pKa of [M–OH2]n+ complexes and 
fluorescence maxima shifts of 10-methylacridone–metal ion salt complexes (Table 1.1).90-91 The 
Lewis acidity of these ions varies widely allowing for a wide range of control over substrate 





























Table 1.1 Lewis acid induced shifts of 10-methylacridone florescence lmax as a measure of 
relative Lewis acidity.91 
 
Lewis Acid lmax Florescence Energy (eV) 
Fe(ClO4)3  478 2.59 
Sc(OTf)3  474 2.62 
Fe(ClO4)2  471 2.63 
Cu(ClO4)2  471 2.63 
Co(ClO4)2  470 2.64 
(C6F5)2SnBr2  470 2.64 
Lu(OTf)3  461 2.69 
Y(OTf)3  460 2.7 
La(OTf)3  458 2.71 
Zn(OTf)2  456 2.72 
Ph3SnCl  455 2.72 
Bu2SnCl2  453 2.74 
(C6F5)3SnBr  452 2.74 
Mg(ClO4)2  451 2.75 
Ca(ClO4)2  449 2.76 
Sr(ClO4)2  445 2.79 
Ba(ClO4)2  444 2.79 
LiClO4  442 2.81 
NaClO4  437 2.84 
Mn(ClO4)2  435 2.85 
10-methylacridone 432 2.87 
 
 Cooperation between transition metal catalysts and Lewis acids as substrate or 
intermediate activators has been realized as a powerful strategy for controlling chemical 
reactivity and catalysis in organic synthesis.92-93 In these reactions, generally either the transition 
metal complex or substrate is too inert to allow the reaction to proceed in the absence of the 
Lewis acid. Lewis acid cooperation via activation of the substrate lowers barriers and promotes 
the reaction. For example, the reaction of zirconacyclopentadienes with isocyanates requires a 
Lewis acid cocatalyst (Figure 1.9).94 The Lewis acid is proposed to activate the isocyanate and 
promote insertion into the zirconacyclopentadiene. Upon insertion, the Lewis acid was also 
proposed to interact with reaction intermediates to promote metathesis and product formation. In 
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another example, the palladium catalyzed dimerization of vinyl arenes is promoted by an 
In(OTf)3 Lewis acid cocatalyst.95 The indium trication activates vinyl arenes to nucleophilic 
attack by Pd(0) complexes. The resulting proposed zwitterionic Pd+–alkyl–In– intermediate then 




Figure 1.8 Lewis acid promoted reaction of zirconacyclopentadienes with isocyanates to form 
iminocyclopentadienes.  
 
Lewis acids can accelerate numerous transition metal-catalyzed reactions. The positive 
influence of the Lewis acid has, in many cases, been attributed to interactions between the Lewis 
acid and the metal-bound substrate. For reactions involving carbon monoxide as a substrate, for 
example, the carbonyl ligand can interact with a Lewis acid during or after C–C bond 
formation.96-101 In cases where pendent macrocycles were present as part of a ligand scaffold and 
positioned the Lewis acid near the metal center, carbonyl activation or acyl stabilization has been 
proposed (Figure 1.7).83, 102-103 Pincer-crown ether Ir complexes have previously been shown to 






































carbonylation catalysis.104-105 Although the role of the Lewis acid in the mechanisms of these 
reactions is not fully understood, postulated transition states include those wherein a cation 
complexed in the pendent crown ether of the molecule interacts with a carbonyl ligand, 
activating it towards nucleophilic attack by a methyl ligand (Figure 1.7). 
 
Figure 1.9 Select examples of macrocycle containing complexes in which a Lewis acid is 
proposed to interact with carbonyl or acyl ligands bound to the metal center. 
 
Positioning activated substrates near the active site of a pincer-crown ether complex 
provides an opportunity for controlling catalysis based on the extent of substrate activation via 
the Lewis acidity of the cationic additive. If the substrate is involved in the rate-determining 
steps of the reaction, activation with Lewis acids could lower barriers to make the reactions 
proceed faster. Additionally, if a given reaction does not proceed with an unactivated substrate, 
but proceeds in the presence of a Lewis acid additive, switchable bimetallic catalysis or substrate 
selective reactivity becomes possible.  
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CHAPTER 2: CONNECTING NEUTRAL AND CATIONIC PATHWAYS IN NICKEL-
CATALYZED INSERTION OF BENZALDEHYDE INTO A C−H BOND OF 
ACETONITRILE 
 
Reproduced with permission from Smith, J. B.; Miller, A. J. M. “Connecting Neutral and 
Cationic Pathways in Nickel-Catalyzed Insertion of Benzaldehyde into a C−H Bond of 




 Organonickel complexes orchestrate an array of molecular elaborations,1-8 but nickel 
catalysts have lagged behind precious metals in the functionalization of C−H bonds.6-8 The 
choice of substrate can be a deciding factor in nickel-mediated C−H functionalization: substrates 
containing a directing group can hold a C−H bond in close proximity to the metal center,9-13 or 
substrates containing relatively acidic C−H bonds can facilitate pathways that rely on 
deprotonation.14-15  
Acetonitrile is an attractive substrate for nickel-catalyzed C−C bond-forming reactions 
because the sp3 C−H bond is relatively acidic (pKa = 25 in H2O)16 and the products would 
contain a valuable nitrile functionality. Direct deprotonation of acetonitrile is often impractical or 
not tolerated by nearby functional groups, motivating the development of catalytic methods that 
avoid stoichiometric amounts of strong base.  
This article describes the insertion of benzaldehyde into a C−H bond of acetonitrile 
(Scheme 2.1) catalyzed by asymmetric Ni aminophosphinite (NCOP) pincer complexes with 
little or no base added. Only two nickel catalysts are found among the handful17-22 of late-
transition-metal catalysts known to carry out this cyanomethylation reaction,23-24 which produces 
 26 
synthetically useful β-hydroxy nitriles.25-27 In 2005, Ozerov and co-workers reported a cationic 
Ni catalyst that required stoichiometric base to couple nitriles and aldehydes.23 In 2013, Guan 
and co-workers isolated a C-bound cyanomethyl species (Ni−CH2CN) that proved to be a highly 
active catalyst for C−H insertion without added base, with a turnover number (TON) of up to 
82,000.24 
 
Scheme 2.1 Insertion of benzaldehyde into a C−H bond of acetonitrile. 
 
The two Ni catalysts were proposed to operate through quite different mechanisms, 
despite the fact that both are supported by pincer ligands. The cationic, base-promoted catalyst 
was proposed to react through the Lewis acid mechanism shown in Scheme 2.2A: nitrile binding 
to the Ni catalyst would render the acetonitrile more acidic, facilitating deprotonation by the 
added base; the resulting N-bound cyanomethyl species would then undergo nucleophilic attack 
on the aldehyde to form the C−C bond.23 The neutral, base-free catalyst was proposed to react 
through the organometallic mechanism shown in Scheme 2.2B: a highly nucleophilic Ni 
alkoxide would facilitate C−H bond activation by a “concerted metalation−deprotonation”-type 









Scheme 2.2 A) Base-promoted and B) Base-free nickel catalyzed hydrocyanomethylation 
catalytic cycles. 
 
Considering the proposed mechanisms in Scheme 2, we hypothesized that a Ni catalyst 
supported by our pincer-crown ether ligand framework could utilize the aza-crown ether donor to 
hold a Lewis acidic cation near the Ni center and accelerate the catalytic reaction.29 In addition to 
numerous examples of Lewis acid-promoted insertion reactions,30-32 we were also aware that a 
related Ru catalyst showed improved aldehyde cyanomethylation yields in the presence of 10% 
NaPF6.21 With this hypothesis in mind, we set out to synthesize new pincer-crown ether 
complexes of nickel and assess their catalytic activity for the insertion of benzaldehyde into a 
C−H bond of acetonitrile. While the asymmetric NCOP pincer framework can indeed support 
catalytic insertion of benzaldehyde into acetonitrile, we were surprised to find that lithium salts 
inhibit the reaction (Na+ and K+ had no effect on the rate). Mechanistic studies to probe the 
origin of the cation-triggered deactivation revealed that catalysis could be reinitiated by the 
addition of base, suggesting a connection between the neutral and cationic precatalysts. 
2.2 Synthesis and Characterization 
 
 Metalation of the previously reported pincer-crown ether ligand containing an aza-15-
crown-5 macrocycle,29 (15c5NCOPiPr)H, was accomplished by heating a toluene solution of the 
[Ni] N
+





























ligand and NiBr2(DME) (DME = dimethoxyethane) at 65 °C for 3 h in the presence of 3 equiv of 
NEt3 (Scheme 2.3). The bromide complex (k3-15c5NCOPiPr)Ni(Br) (1-15c5) was isolated in high 
yield using this procedure adapted from Zargarian, who reported the first nickel NCOP 
complexes using related ligands featuring simple secondary or tertiary amine donors.33-34 Full 
synthetic details are provided in the Experimental Section. 
 
Scheme 2.3 Synthesis of (k3-15c5NCOPiPr)Ni(Br) (1-15c5). 
 
The 1H NMR spectrum of 1-15c5 is consistent with a Cs-symmetric solution structure, as 
a single benzylic methylene linker resonance and two isopropyl doublets of doublets were 
observed. A singlet (d 200) was observed in the 31P{1H} NMR spectrum. Slow evaporation of an 
ether solution of 1-15c5 under fostered the growth of yellow crystals suitable for X- ray 
diffraction analysis. The solid-state structure of 1-15c5 (Figure 2.1) confirmed the expected 
tridentate meridional coordination mode of the ligand in a distorted square-planar geometry, with 

























Figure 2.1 Structural representation of 1-15c5 with ellipsoids drawn at the 50% probability 
level. Hydrogen atoms omitted for clarity. Selected distances (Å) and angles (deg): Ni–P 
2.103(2), Ni–N 2.032(4), Ni–Br 2.343(1), Ni–C1 1.844(5), P–Ni–Br 94.40(5), P–Ni–C1 
81.98(17), N–Ni–Br 99.38(12), N–Ni–C1 83.9(2). 
 
Addition of 1-15c5 to 1.1 equiv of KOtBu suspended in toluene resulted in an immediate 
color change from yellow to red-orange accompanied by precipitation of KBr and the clean 
formation of (k3-15c5NCOPiPr)Ni(OtBu) (2-15c5 ) (Scheme 2.4). The 1H NMR spectrum of 2-
15c5 was similar to that of 1-15c5, with an additional characteristic tert-butoxide methyl singlet 
(d 1.42). The 31P{1H} spectrum of 2-15c5 showed a significant upfield shift relative to the 
corresponding bromide complex 1-15c5 (d 190). An analogous diethylamino-substituted nickel 
precatalyst, (k3-EtNCOPiPr)Ni(OtBu) (2-Et), was prepared by treating the previously reported 
bromide complex (k3-EtNCOPiPr)Ni(Br) (1-Et)33 with KOtBu (Scheme 2.4). In contrast to the 
reaction with the macrocycle-containing 1-15c5, the color did not change immediately, and 
complete conversion required excess KOtBu and extended reaction times (5 h for 2-Et vs 1 h for 
2-15c5).We hypothesize the pendent crown aids in solubilizing the base, facilitating the reaction. 
The 1H and 31P{1H} NMR spectra of 2-Et were similar to those of 2-15c5. Complexes 2-15c5 
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and 2-Et are hygroscopic and decompose on contact with moisture (apparently to form a Ni 
hydroxide and free tBuOH); samples were stored under N2 at −30 °C. 
 
Scheme 2.4 Synthesis of (k3-15c5NCOPiPr)Ni(OtBu) (2-15c5) and (k3-EtNCOPiPr)Ni(OtBu) (2-Et). 
 
Cationic nickel complexes were also accessible from the corresponding bromide. 
Addition of AgPF6 to bromide 1-15c5 in CH2Cl2 containing acetonitrile resulted in precipitation 
of AgBr and the formation of [(k3-15c5NCOPiPr)Ni(NCCH3)][PF6] (3-15c5) (Scheme 2.5). Two 
new signals were noted in the 31P{1H} NMR spectrum, a singlet corresponding to the bound 
ligand (d 203) and a septet corresponding to the PF6− counterion (d −143). The diethyl analogue 
[(k3-EtNCOPiPr)Ni(NCCH3)][PF6] (3-Et) was obtained using a similar procedure (Scheme 2.5).  
 
Scheme 2.5 Synthesis of [(k3-15c5NCOPiPr)Ni(NCCH3)][PF6] (3-15c5) and [(k3-
EtNCOPiPr)Ni(NCCH3)][PF6] (3-Et). 
 
The acetonitrile complexes 3-15c5 and 3-Et exhibit distinct NMR spectra when dissolved 
in CD2Cl2, in contrast to the similar spectra observed in CD3CN. In the case of 3-Et, the NMR 
resonances in CD2Cl2 were sharp and clearly showed a singlet corresponding to the methyl group 
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poorly resolved resonances at room temperature, however. The fluxional behavior is attributed to 
competitive Ni binding by the ether groups in the macrocycle, in analogy to related Ir systems.29 
When the NMR probe was cooled to −50 °C, the resonances for free acetonitrile and Ni- bound 
acetonitrile sharpened, and the major product was the bound acetonitrile complex (Figure 2.2). 
Consistent with a labile acetonitrile ligand, elemental analysis of solid 3-15c5 exposed to high 
vacuum was consistent with loss of acetonitrile. 
 
Figure 2.2 1H NMR spectra of a CD2Cl2 solution containing CH3CN and 
[(15c5NCOPiPr)Ni(NCCH3)][PF6] (3-15c5) between 213 K and 298 K 
 
2.3 Catalytic Hydrocyanomethylation of Benzaldehyde 
 
 The nickel complexes were assessed as C−H insertion catalysts, as shown in Scheme 2.6 
and summarized in Table 2.1. The tert-butoxide complexes 2-15c5 and 2-Et are active catalysts 
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benzaldehyde in acetonitrile (∼10% v/v) at ambient temperature. Reactions with the 
diethylamino- and aza-15-crown-5-containing complexes each proceeded with a turnover 
number (TON) of ∼100 (Table 2.1, entries 1 and 2). The uncertainty in the TON is estimated at 
±5 turnovers on the basis of triplicate catalytic runs under identical conditions. Given that some 
strong bases can catalyze similar reactions,35 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU), 
LiOtBu, and KOtBu were tested as catalysts in the absence of Ni (Table 2.1, entries 7−9). DBU 
and LiOtBu did not catalyze the reaction, while KOtBu showed sluggish catalytic activity 
compared with the Ni catalyst. 
 
Scheme 2.6 Hydrocyanomethylation catalysis conditions. 
 
Table 2.1 Comparing catalysts and conditions for benzaldehyde insertion into acetonitrile.a 
Entry Catalyst Base Time TON Yield (%) 
1 2-15c5 None 24 h 104 52 
2 2-Et None 24 h 105 52 
3 3-15c5 None 120 h 0 0 
4 3-15c5 1 mol % DBU 120 h 100 50 
5 3-Et None 120 h 0 0 
6 3-Et 1 mol % DBU 120 h 91 46 
7 None 1 mol % DBU 120 h 0 0 
8 None 0.5 mol % KOtBu 24 h 24 12 
9 None 0.5 mol % LiOtBu 24 h 1 1 
 aConditions: 0.5 mol % catalyst, 3 mL 1 M benzaldehyde in CH3CN, 25˚ C. 
 The cationic complexes 3-15c5 and 3-Et were completely inactive under the typical 
conditions described above (Table 2.1, entries 3 and 5), consistent with Ozerov’s observation 
that added base is required for activity with [(PNP)Ni(NCCH3)][OTf].23 Accordingly, catalysis 
commenced when 1 mol % DBU (2 equiv relative to the catalyst) was added to the reaction 













catalyst (3-15c5 or 3-Et). Reaction monitoring by 1H NMR spectroscopy revealed >50% 
conversion after 120 h at room temperature. The cationic species are significantly less active 
than the tert-butoxide precatalysts even in the presence of a base. As with the neutral 
precatalysts, the diethylamino- and aza-15-crown-5-containing complexes showed essentially 
identical results (Table 2.1, entries 4 and 6). 
 
Figure 2.3 Turnover number (TON) for the insertion of benzaldehyde into acetonitrile catalyzed 
by 0.5 mol % [(κ3-15c5NCOPiPr)Ni(NCCH3)][PF6] (3-15c5) as a function of added DBU. 
Conditions: 0.5 mol % 3-15c5, 3 mL 1 M benzaldehyde in CH3CN, 25˚ C, 24 h. 
 
 The cationic catalyst system is noteworthy for operating with only catalytic amounts of 
base. The other cationic Ni catalyst required elevated temperatures and stoichiometric base for 
best results.23 In fact, additional base had almost no impact on the efficiency of 3-15c5. Variation 
of the concentration of base revealed saturation behavior at low levels of DBU (Figure 2.3), with 
base beyond 1 mol % giving no significant rate enhancement. 
 Having assessed the baseline catalytic performance for neutral and cationic catalysts, we 
turned to an examination of the effect of cationic Lewis acids on the catalytic performance. We 













interactions between the substrates and the Lewis acid. However, no rate enhancement was 
observed when the catalysis was carried out in the presence of added NaPF6 or KPF6 (Table 2.2), 
regardless of the overall charge of the precatalyst or whether a crown ether group was present. 
This result stands in contrast to Ru-catalyzed cyanomethylation of aldehydes, which exhibit 
significant rate enhancements in the presence of NaPF6.21 
Table 2.2 Hydrocyanomethylation in the presence of Lewis acidsa. 
 
Entry Catalyst Base Cation (equiv. to catalyst) Time TON 
1 2-15c5 None 1 LiPF6 24 h 14 
2  None 1 NaPF6 24 h 98 
3  None 1 KPF6 24 h 96 
4 2-Et None 1 LiPF6 24 h 79 
5  None 1 NaPF6 24 h 106 
6  None 1 KPF6 24 h 109 
7 3-15c5 1 mol% DBU 1 LiPF6 120 h 117 
8  1 mol% DBU 1 NaPF6 120 h 108 
9  1 mol% DBU 1 KPF6 120 h 120 
10 3-Et 1 mol% DBU 1 LiPF6 120 h 95 
11  1 mol% DBU 1 NaPF6 120 h 88 
12  1 mol% DBU 1 K 120 h 96 
aConditions: 0.5 mol% catalyst, 3 mL 1M benzaldehyde in CH3CN, 298 K. 
 
Even more surprisingly, addition of LiPF6 had a dramatic inhibitory effect on the 
catalysis. As illustrated in Figure 2.4, under conditions in which 2-15c5 proceeded to 105 
turnovers in the absence of Li+, the reaction halted after less than 15 turnovers in the presence of 
small amounts of LiPF6. Some deactivation was also observed in reactions catalyzed by 2-Et, but 
the effect was much less dramatic than with 2-15c5, suggesting that the macrocycle aids the 
deactivation process. Catalyst deactivation was unique to the tert-butoxide complexes 2-15c5 
and 2-Et, as the lithium salts did not inhibit catalysis by the cationic complexes 3-15c5 and 3-Et.  
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Figure 2.4 (A) Turnover number (TON) for the insertion of benzaldehyde into acetonitrile 
catalyzed by 2-15c5 alone (filled dark blue circles), 2-15c5 with 0.5 mol % Li+ (empty light blue 
circles), 2-Et alone (filled dark red squares), and 2-Et with 0.5 mol % Li+ (empty light red 
squares). (B) TON after 24 h as a function of the equivalents of LiPF6 added relative to catalyst. 
Conditions: 0.5 mol % catalyst, 3 mL 1 M benzaldehyde, 25˚ C. 
 
2.4 Mechanistic Studies 
 
 In order to better understand the origin of the Li+ inhibition, NMR studies were carried 
























CD3CN at room temperature led to complete conversion to a new species as observed by 1H and 
31P{1H} NMR spectroscopy after 40 min, along with a resonance characteristic of free tBuOH.36 
The product is assigned as the C-bound cyanomethyl complex (k3-15c5NCOPiPr)Ni(CD2CN) (4-
15c5-d2), as shown in Scheme 2.7.15, 24 This formulation was confirmed by the preparation of an 
authentic sample via the reaction of LiCH2CN with bromide 1-15c5. The spectroscopic 
signatures of authentic (k3-15c5NCOPiPr)Ni(CH2CN) (4-15c5) confirmed that the tert-butoxide 
complex 2-15c5 reacts with acetonitrile to give 4-15c5 (or 4-15c5-d2 in CD3CN). The Ni alkyl 
hydrogen atoms appear as a doublet (d 0.11, JPH = 5 Hz) in the 1H NMR spectrum of 4-15c5 and 
the methylene carbon atom as a doublet (d −15.16, JPC = 12 Hz) in the 13C{1H} NMR spectrum, 
confirming the presence of a Ni−C bond.24, 37-39 No broadening or other signs of fluxionality that 
might suggest interconversion between C-bound and N-bound forms of the cyanomethyl ligand 
were observed.15 
 
Scheme 2.7 Independent synthesis of (k3-15c5NCOPiPr)Ni(CH2CN) (4-15c5) and (k3-
15c5NCOPiPr)Ni(OC(H)(Ph)(CH2CN)) (5-15c5). 
 
Cyanomethyl species have been proposed as intermediates in related systems,24 so a 
catalytic run was carried out with 0.5 mol % isolated 4-15c5 in a 1 M benzaldehyde solution in 
CH3CN. The observed TON of 100 is similar to the TON for 2-15c5 (104±5); 4-15c5 is therefore 
a viable catalytic intermediate.  
2-15c5
CD3CN, 25 ºC, 40 min
– tBuOH
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Figure 2.6 31P{1H} NMR spectra showing formation of cyanomethyl complex 4-15c5-d2 and 
alkoxide complex 5-15c5-d2. 
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 After formation of the Ni−CD2CN fragment, addition of 1 equiv of benzaldehyde led to 
complete conversion to another new species (Scheme 2.7 and Figures 2.5 and 2.6). 1H NMR 
spectroscopy showed four sets of isopropyl methyl doublets of doublets, consistent with a 
lowering of the symmetry due to the presence of a chiral center. A broad new resonance was 
observed in a region consistent with a benzylic position (d 4.59) formed upon aldehyde insertion. 
The resonance at d 4.59 correlated with a nitrile carbon (d 121.1) and several aromatic carbons in 
a 1H−13C HMBC experiment,36 further suggesting C−C bond formation. To aid characterization, 
the protio analogue was generated in CH3CN and characterized by NMR spectroscopy with the 
aid of a C6D6 capillary to lock and shim. In CH3CN solvent, a diastereotopic pair of methylene 
protons (absent in samples prepared using CD3CN) appeared around 3.5 ppm, and the benzylic 
resonance at d 4.59 became a sharp triplet (Figure 2.7). These two resonances exhibited strong 
correlation in a 1H−1H COSY experiment (Figures 2.8). On the basis of this spectroscopic 
evidence, the product is assigned as the cyanoalkoxide complex (k3-
15c5NCOPiPr)Ni(OC(H)(Ph)(CH2CN)) (5-15c5).  
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Figure 2.7 1H NMR spectrum of (15c5NCOPiPr)Ni(OC(H)(Ph)(CH2CN)) (5-15c5) in CH3CN. 
Made from 2-15c5 in situ. Capillary containing C6D6 and HMDSO used to lock and shim. 
 
 
Figure 2.8 1H-1H COSY NMR spectrum of (15c5NCOPiPr)Ni(OC(H)(Ph)(CH2CN)) (5-15c5) in 




Cyanoalkoxide species have been proposed as intermediates in Ni-catalyzed 
cyanomethylation24 but have not been isolated or fully characterized because of their high 
reactivity in the presence of acetonitrile. For example, treatment of (POCOP)Ni(CH2CN) with 
benzaldehyde in CD3CN formed the deuterated product (POCOP)Ni(CD2CN) and the free 
cyanoalcohol, and the cyanoalkoxide was not observed.24 The surprising stability of 
cyanoalkoxide 5-15c5 has allowed for a much more detailed characterization of this species, 
presumably because the (NCOP)Ni system is less reactive with acetonitrile. 
Catalytic reactions under typical conditions (0.5 mol % catalyst, 1 M benzaldehyde, 25 
°C) were also monitored in situ by NMR spectroscopy in CH3CN. The precatalyst 2-15c5 formed 
both (k3-15c5NCOPiPr)Ni(CH2CN) (4-15c5) and (k3-15c5NCOPiPr)Ni(OC(H)(Ph)(CH2CN)) (5-
15c5) at early times (4-15c5:5-15c5 ratio ≈ 50:50), but the ratio of the intermediates changed 
over the course of the reaction, with cyanoalkoxide complex 5-15c5 slowly diminishing over 48 
h.36 The two intermediates constituted >70% of the Ni species during the reaction. When 
precatalyst 2-Et was monitored analogously, 31P NMR resonances were observed at chemical 
shifts very similar to those for 4-15c5 and 5-15c5, suggesting that once again both the 
cyanomethyl complex 4-Et and the cyanoalkoxide complex 5-Et were present at the onset of 
catalysis (4-Et:5-Et ratio ≈ 60:40) before the speciation shifted almost entirely to the 
cyanoalkoxide complex 5-Et.36 The differences in speciation over time for 2-Et and 2-15c5 were 
surprising and suggest that relatively minor changes in the catalyst structure might lead to 
changes in the turnover-limiting step. Interestingly, the cationic species 3-15c5 and 3-Et were 
observed among several unidentified Ni species that grew in slowly over time during the 
reaction. Under these base-free conditions, the cationic species are likely deactivated forms of 
the catalyst (Table 2.1, entries 3 and 5). 
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The presence of both cyanomethyl and cyanoalkoxide species during catalysis led us to 
investigate the reversibility of the insertion step. To probe for reversibility, 5-15c5 was 
synthesized in CH3CN as described above, isolated as a crude solid by removal of volatiles under 
vacuum, and redissolved in CD3CN. Over the course of 2 h, the diastereotopic methylene protons 
of 5-15c5 disappeared and the benzylic triplet resonance was replaced by a broad singlet.36 The 
data are consistent with reversible C−C bond formation (Scheme 2.8): deinsertion of 
benzaldehyde would be followed by activation of CD3CN to form a Ni−CD2CN fragment and 
reinsertion of benzaldehyde to generate the isotopologue 5-15c5-d2. Rapid H/D exchange of 
cyanomethylnickel species has been previously observed, and aldehyde insertion has been 
proposed to be reversible in related systems.24 
 
Scheme 2.8 Reversibility of benzaldehyde insertion into the C–H or C–D bonds of CH3CN or 
CD3CN with catalyst 5-15c5. 
 
When tert-butoxide catalyst 2-15c5 was treated with LiPF6 and monitored during 
turnover, alkoxide abstraction occurred immediately to form the cationic acetonitrile complex 3-
15c5 in >90% yield.36 Essentially no turnover was observed under these conditions; 3-15c5 is 
 14 
during the reaction. Under these base-free conditions, the cationic species are likely de ctivated 
forms of the catalyst.  
Scheme 8.
The presence of both yanomethyl and cyano-alkoxide species during catalysis led us to 
investigate the reversibility of the insertion step. To probe for reversibility, 5-15c5 was 
synthesized in CH3CN as described above, isolated as a crude solid by removal of volatiles under 
vacuum, and re-dissolved in CD3CN. Over the course of 2 h, the diastereotopic methylene 
protons of 5-15c5 disappeared and the benzylic triplet resonance was replaced by a broad singlet 
(Figures S17 and S18 in the SI). The data are consistent with reversible C−C bond formation 
(Scheme 8): de-insertion of benzaldehyde would be followed by activation of CD3CN to form a 
Ni−CD2CN fragment and re-insertion of benzaldehyde to generate the isotopologue 5-15c5-d2. 
Rapid H/D exchange of cyanomethyl nickel species has been previously observed, and aldehyde 
insertion has been proposed to be reversible in related systems.24 The differences in speciation 
over time for 2-Et and 2-15c5 were surprising and suggest that relatively minor changes in 



















































inactive in the absence of a base additive (Table 2.1). The identity of the deactivated Ni catalyst 
strongly suggests that the inhibitory role of Li+ involves alkoxide abstraction to form 
[(NCOP)Ni(NCCH3)]+ and either LiOtBu or LiOC(H)(Ph)(CH2CN). Accordingly, a white 
precipitate was observed upon addition of LiPF6 to 2-15c5. The lack of inhibition by Na+ and K+ 
salts is attributed to the greater solubility of the alkoxide salts that would be formed.40-41 
 The catalytic activity could be stopped and started by addition of LiPF6 followed by 
addition of DBU. A catalytic reaction was initiated under standard conditions of 0.5 mol % 2-
15c5 and 1 M benzaldehyde in CH3CN (C6D6 capillary for lock signal) and followed by 1H NMR 
spectroscopy (Figure 2.9). Addition of 0.5 mol % LiPF6 (red line in Figure 2.9) effectively shut 
down the reaction. After ∼3 h, catalysis was reinitiated by injection of 1 mol % DBU (green line 
in Figure 2.9), albeit at a lower rate consistent with the longer reaction times required by cationic 
catalysts paired with DBU (Table 2.1). Alkoxide abstraction by lithium additives connects the 
neutral catalysts 2-15c5 and 2-Et with the cationic acetonitrile complexes 3-15c5 and 3-Et. 
 
 
Figure 2.9 TON over time for two parallel reactions containing 0.5 mol % 2-15c5 and 1 M 
benzaldehyde in CH3CN (C6D6 capillary) assessed by 1H NMR. The first experiment (filled blue 
circles) was allowed to continue unabated for 17 h, while the second experiment (empty light-
blue circles) was treated with 0.5 mol % LiPF6 after 2.4 h (red line), resulting in catalyst 












Independently synthesized samples of the cationic precatalyst 3-15c5 exhibited no 
reaction upon dissolution in CD3CN, with no evidence for the formation of a Ni cyanomethyl 
species. Addition of 1 equiv of DBU (pKa = 24.3 in CH3CN),42 however, led to a mixture of 
species, including a broad resonance indicating a fluxional process attributed to competitive 
binding of DBU and CD3CN (Scheme 2.9 and Figures 2.10 and 2.11).23 Addition of 10 equiv of 
benzaldehyde to this solution initiated catalysis (Figures 2.10 and 2.11). Benzaldehyde was 
consumed, and the cyanoalcohol product grew in. The major Ni species during catalysis were the 
DBU adduct and 3-15c5, but about 10% of the Ni was present in the form of the insertion 
product, cyanoalkoxide 5-15c5-d2. Significantly less of this cyanoalkoxide complex 5-15c5-d2 
was present in the case of the cationic catalyst paired with base, compared with catalytic 
reactions involving tert-butoxide complex 2-15c5. These studies establish the viability of nickel 
cyanomethyl and cyanoalkoxide species as cyanomethylation intermediates. Furthermore, the 
neutral and cationic precatalysts both generate the same cyanoalkoxide intermediate, albeit in 
different steady-state concentrations.  
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In an attempt to avoid the formation of a base adduct of nickel, the strong, bulky 
phosphazene base tBuNP-(pyrrolidinyl)3 (tBuP1, pKa = 28.4 in CH3CN)42 was also examined. The 
addition of a slight excess of tBuP1 to the acetonitrile complex 3-15c5 in CD3CN resulted in rapid 
deprotonation to form the cyanomethyl complex 4-15c5-d2 (Scheme 9). In contrast to the 
analogous reaction with DBU, no evidence of tBuP1 coordination to Ni was observed. A sharp 
singlet in the 31P{1H} NMR spectrum (d 197) indicated that 4-15c5-d2 was formed in high yield, 
and broad resonances for tBuP1 and its conjugate acid were also observed (Figure 2.12). As 
expected of a solution containing the cyanomethylnickel complex, the addition of 25 equiv of 
benzaldehyde initiated catalysis. During turnover, a sharp singlet characteristic of the conjugate 
acid of tBuP1 suggested that the base was fully protonated. The cyanoalkoxide complex 5-15c5-d2 
was the major species during catalysis, again contrasting with the situation with DBU, which 
generated only a small amount of 5-15c5-d2.  
 
 
Scheme 2.9 Reaction of 3-15c5 and 3-Et with DBU and tBuP1.  
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 In an attempt to avoid formation of a base adduct of nickel, the strong, bulky base 
phosphazene base tBuNP(pyrrolidinyl)3 (tBuP1, pKa = 28.4 in CH3CN)41 was also examined. 
Addition of a slight excess of tBuP1 to the acetonitrile complex 3-15c5 in CD3CN resulted in rapid 
deprotonation to form cyanomethyl 4-15c5-d2 (Scheme 9). In contrast to the analogous reaction 
with DBU, no evidence of tBuP1 coordination to Ni was observed. A sharp singlet in the 31P{1H} 
NMR spectrum (δ 197) indicated that 4-15c5-d2 was formed in high yield, and broad resonances 
for tBuP1 and its conjugate acid were also observed (Figure S27 in the SI). As expected of a 
solution containing the cyanomethylnickel complex, addition of 25 equiv benzaldehyde initiated 
catalysis. During turnover, a sharp singlet characteristic of the conjugate acid of tBuP1 suggested 
that the base was fully protonated. The cyano-alkoxide complex 5-15c5-d2 was the major species 
during catalysis, again contrasting the situation with DBU, which generated only a small amount 
of 5-15c5-d2.  
 In a separate experiment, 0.5 mol% cationic precatalyst 3-15c5 and 1.0 mol% tBuP1 were 
combined in a 1M benzaldehyde solution in CH3CN. Benzaldehyde insertion proceeded 
smoothly, with the TON reaching 109 after 24 h. Whereas the 3-15c5/DBU combination was 


































Figure 2.12 Subsequent addition of tBuP1 and benzaldehyde to 3-15c5. 
 
In a separate experiment, 0.5 mol % cationic precatalyst 3-15c5 and 1.0 mol % tBuP1 were 
combined in a 1 M benzaldehyde solution in CH3CN. Benzaldehyde insertion proceeded 
smoothly, with the TON reaching 109 after 24 h. Whereas the 3-15c5/DBU combination was 
much slower than the neutral tert-butoxide precatalyst 2-15c5, the 3-15c5/tBuP1 combination 
provided similar levels of activity as 2-15c5. (In the absence of any Ni species, tBuP1 exhibited a 
TON of only 12). 
Scheme 2.10 depicts a proposed mechanism that is consistent with the experimental data. 
The neutral pathway, shown in green, involves interconversion of nickel cyanomethyl (4-15c5 
and 4-Et) and cyanoalkoxide (5-15c5 and 5-Et) species. Both of these species were 
independently synthesized and observed during turnover, and the isolated cyanomethyl complex 
4-15c5 exhibited catalytic activity essentially identical to that of the tert-butoxide complex 2-

















aldehyde insertion and C−H bond activation steps are reversible. In further support of the key 
role of equilibria, catalytic reactions containing 0.5 mol % 2-15c5 and 50 mol % tBuOH showed 
markedly decreased activity (TON = 62 vs TON = 104 in the absence of added alcohol). Product 
inhibition might therefore explain why reactions tended to slow down before reaching 
completion (50−60% yield). 
 
Scheme 2.10 Proposed catalytic mechanism. 
Deactivation of the neutral cycle occurs when Li+ abstracts the tert-butoxide or 
cyanoalkoxide, leading to insoluble precipitates and generating cationic species 3-15c5 or 3-Et, 
as shown in dashed red. The cationic pathway, shown in blue, requires a base for activity. DBU 
can deprotonate Ni-bound acetonitrile, but DBU also displaces the acetonitrile ligand, engaging 
an unproductive binding equilibrium. This is consistent with the pseudo-zeroth-order dependence 
of the catalysis rate on DBU (Figure 2.3). The conjugate acid H−DBU+ (pKa = 24.3 in CH3CN)42 
is also more acidic than tBuOH (pKa ∼ 40 in CH3CN),43 which may facilitate removal of the 
cyanoalkoxide species from the cycle by protonolysis. It is difficult to rule out the alternative 
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N-bound cyanomethyl complex that undergoes outer-sphere nucleophilic attack on 
benzaldehyde.23 We observed the same cyanoalkoxide intermediate when monitoring catalytic 
reactions carried out with neutral and cationic precatalysts, however, suggesting a relationship 
between the neutral and cationic cycles. When the stronger, bulkier phosphazene base tBuP1 is 
employed, the unproductive binding equilibrium is avoided (Scheme 2.10), and the base can be 
considered an initiator that quickly generates the more active cyanomethyl catalyst 4-15c5. The 
fully protonated state of the phosphazene during catalysis suggests a mechanism in which tBuP1 
deprotonates the Ni-bound acetonitrile to enter the neutral cycle in Scheme 2.10. 
2.5 Conclusions 
 
 Neutral and cationic NCOP Ni complexes are viable catalysts for the insertion of 
benzaldehyde into a C−H bond of acetonitrile. Subtle differences between the catalyst resting 
states were observed for macrocycle-containing pincer-crown ether complexes and pincer 
complexes with a diethylamine donor. A surprising deactivation occurred when neutral Ni tert- 
butoxide catalysts were treated with LiPF6, which revealed a pathway connecting the neutral 
catalysts to cationic Ni species that are catalytically inactive in the absence of base. Catalytic 
activity switched off by the addition of Li+ could be switched back on by addition of DBU. 
These in situ mechanistic studies revealed a link between the two precatalysts and provided more 
detailed characterization of a proposed cyanoalkoxide intermediate. 
2.6 Experimental Section 
 
General Considerations 
Standard vacuum line and glovebox techniques were utilized to maintain a N2 atmosphere 
during manipulation of all compounds, unless otherwise noted. NMR-scale reactions were 
prepared in a glovebox and monitored in Teflon-sealed tubes. Organic solvents were dried and 
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degassed with argon using a Pure Process Technology solvent system and stored over 3 Å 
molecular sieves. Under standard glovebox operating conditions, pentane, diethyl ether, benzene, 
toluene, and tetrahydrofuran were used without purging, so traces of those solvents were present 
in the atmosphere and in the solvent bottles. 1H, 31P, and 13C NMR spectra were recorded on 400, 
500, or 600 MHz spectrometers. NMR characterization data are reported at 25 °C, unless 
specified otherwise. All of the NMR solvents were purchased from Cambridge Isotopes 
Laboratories. Acetonitrile-d3 (CD3CN), benzene-d6 (C6D6), chloroform-d (CDCl3), and 
methylene chloride-d2 (CD2Cl2) were freeze− pump−thaw-degassed three times, dried by 
passage through a small column of activated alumina, and stored over 3 Å molecular sieves. 1H 
and 13C chemical shifts are reported in parts per million relative to residual protio solvent 
resonances.44 All of the 31P resonances are reported relative to 85% H3PO4 external standard (0 
ppm). (15c5NCOPiPr)H,29 (EtNCOPiPr)H,33 (k3-EtNCOPiPr)Ni(Br),33 and LiCH2CN,24, 45 were 
synthesized according to literature procedures. KOtBu was sublimed under reduced pressure 
(0.01 Torr) at 175 °C prior to use. All of the other reagents were commercially available and 
used without further purification. Elemental analyses were performed by Robertson Microlit 
Laboratories (Ledgewood, NJ). 
Single-crystal X-ray diffraction data were collected on a Bruker Smart Apex-II 
diffractometer at 100 ± 2 K with Cu Kα radiation (λ = 1.54175 Å). Diffraction profiles were 
integrated using the SAINT software program. Absorption corrections were applied using 
SADABS. The structure was solved using direct methods and refined using the XL refinement 
package via the least-squares method. Hydrogen atoms were generated theoretically and refined 
isotropically with fixed thermal factors.  
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Synthetic Procedures 
Synthesis of (15c5NCOPiPr)Ni(Br) (1-15c5) 
In a glovebox, a glass Teflon-sealed pressure tube was charged with 168.7 mg (0.547 
mmol) of NiBr2(DME) and 10 mL of toluene. In a separate flask, 241.4 mg (0.547 mmol) of 
(15c5NCOPiPr)H was stirred with 0.229 mL (1.643 mmol) of triethylamine in 15 mL of toluene for 
10 min, and then the resulting mixture added dropwise to the stirring suspension of NiBr2(DME). 
The flask was sealed and heated at 65 °C for 3 h. After heating, the solution was filtered under 
N2, and the filtrate was evaporated to dryness. The resulting yellow oil was extracted with Et2O 
and filtered. Slow evaporation yielded yellow crystals that were washed with 3 × 5 mL of 
pentane and dried under vacuum (288 mg, 91% yield). Single crystals suitable for an X-ray 
diffraction study were grown by slow evaporation of an Et2O solution of 1-15c5. 1H NMR (600 
MHz, C6D6): d 1.18 (dd, 3JHP = 14 Hz, 3JHH = 7 Hz, 6H, CH(CH3)2), 1.50 (dd, 3JHP = 17 Hz, 3JHH 
= 7 Hz, 6H, CH(CH3)2), 2.23 (m, 2H, CH(CH3)2), 3.16 (m, 2H, crown-CH2), 3.24 (m, 4H, 
crown-CH2), 3.31 (m, 4H, crown-CH2), 3.40 (m, 2H, crown-CH2), 3.63 (m, 2H, crown-CH ), 
3.80 (m, 2H, crown-CH ), 4.07 (m, 2H, 22 crown-CH2), 4.14 (m, 2H, crown-CH2), 4.47 (s, 2H, 
ArCH2N), 6.52 (d, 3JHH = 7 Hz, 1H, ArH), 6.63 (d, 3JHH = 8 Hz, 1H, ArH), 6.90 (t, 3JHH = 8 Hz, 
1H, ArH). 13C {1H} NMR (150 MHz, C6D6): d 16.58 (d, 2JCP = 2 Hz, CH3), 17.99 (d, 2JCP = 4 Hz, 
CH3), 28.16 (d, 1JCP = 24 Hz, CH), 56.89 (s, crown-CH2), 65.28 (s, ArCH2N), 69.49 (s, crown- 
CH2), 70.27 (s, crown-CH2), 70.56 (s, crown-CH2), 70.58 (s, crown- CH2), 107.58 (d, 3JCP = 13 
Hz, CAr), 115.38 (d, 4JCP = 2 Hz, CAr), 126.68 (s, CAr), 142.08 (d, 2JCP = 33 Hz, CAr), 153.35 (s, 
CAr), 165.58 (d, 2JCP = 11, CAr). 31P{1H} NMR (161 MHz, C6D6): d 200.4. Anal. Calcd for 
C23H39O5NPNiBr: C, 47.70; H, 6.79; N, 2.42. Found: C, 47.60; H, 6.50; N, 2.38.  
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Figure 2.13 1H NMR spectrum of (15c5NCOPiPr)NiBr (1-15c5) in C6D6. 
 
Figure 2.14 31P{H} NMR spectrum of (15c5NCOPiPr)NiBr (1-15c5) in C6D6. 
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Figure 2.15 13C{H} NMR spectrum of (15c5NCOPiPr)NiBr (1-15c5) in C6D6. 
 
Table 2.3 Crystal data and structure refinement for (15c5NCOPiPr)NiBr (1-15c5). 
 
Identification code  JBS014  
Empirical formula  C23H39NO5PNiBr  
Formula weight  579.14  
Temperature/K  100  
Crystal system  tetragonal  
Space group  P42/n  
a/Å  24.9741(3)  
b/Å  24.9741(3)  
c/Å  8.09970(10)  
α/°  90  
β/°  90  
γ/°  90  
Volume/Å3  5051.83(14)  
Z  8  
ρcalcg/cm3  1.523  
µ/mm-1  3.836  
F(000)  2416.0  
Crystal size/mm3  0.215 × 0.111 × 0.095  
Radiation  CuKα (λ = 1.54178)  
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2Θ range for data collection/°  5.004 to 140.288  
Index ranges  -30 ≤ h ≤ 29, -28 ≤ k ≤ 30, -9 ≤ l ≤ 8  
Reflections collected  30343  
Independent reflections  4785 [Rint = 0.0722, Rsigma = 0.0394]  
Data/restraints/parameters  4785/0/293  
Goodness-of-fit on F2  1.028  
Final R indexes [I>=2σ (I)]  R1 = 0.0313, wR2 = 0.0676  
Final R indexes [all data]  R1 = 0.0454, wR2 = 0.0729  
Largest diff. peak/hole / e Å-3  0.34/-0.35  
 
Synthesis of (15c5NCOPiPr)Ni(OtBu) (2-15c5 ) 
In a glovebox, a 20 mL vial was charged with 10.9 mg (0.097 mmol) of KOtBu and 2 mL 
of toluene. A solution of 51.2 mg (0.088 mmol) of (15c5NCOPiPr)- Ni(Br) in toluene was added 
dropwise, and the resulting solution was allowed to stir for 1 h. The solvent was removed in 
vacuo, and the reaction mixture was extracted with cold pentane (−30 °C) and filtered. The 
solution was evaporated to yield a hygroscopic red-orange oil (47 mg, 93% yield). 1H NMR (400 
MHz, C6D6): d 1.19 (dd, 3JHP = 13 Hz, 3JHH = 7 Hz, 6H, CH(CH3)2), 1.45 (s, 9H, Ni−OC(CH3)3), 
1.56 (dd, 3JHP = 18 Hz, 3JHH = 7 Hz, 6H, CH(CH3)2), 2.20 (m, 2H, CH(CH3)2), 3.36 (m, 14H, 
crown-CH2), 3.80 (m, 2H, crown-CH2), 4.06 (m, 2H, crown-CH2), 4.35 (s, 2H, ArCH2N), 4.44 
(m, 2H, crown-CH2), 6.51 (d, 3JHH = 7 Hz, 1H, ArH), 6.58 (d, 3JHH = 8 Hz, 1H, ArH), 6.90 (t, 
3JHH = 8 Hz, 1H, ArH). 13C {1H} NMR (150 MHz, C6D6): d 17.34 (d, 2JCP = 4 Hz, CH(CH3)2), 
19.32 (d, 2JCP = 6, CH(CH3)2), 29.92 (d, 1JCP = 20 Hz, CH(CH3)2), 36.49 (s, Ni− OC(CH3)3), 
56.38 (s, crown-CH2), 66.46 (s, 1C, ArCH2N), 68.64 (s, Ni−OC(CH3)3), 69.64 (s, crown-CH2), 
70.84 (s, crown-CH2), 71.00 (s, crown-CH2), 71.47 (s, crown-CH2), 107.11 (d, 3JCP = 12 Hz, 
CAr), 115.32 (d, 4JCP = 2 Hz, CAr), 126.05 (s, CAr), 138.24 (d, 2JCP = 35 Hz, CAr), 154.25 (s, CAr), 
165.98 (d, 2JCP = 10 Hz, CAr). 31P{1H} NMR (161 MHz, C6D6): d 189.57. Anal. Calcd for 
C27H48NNiO6P: C, 56.66; H, 8.45; N, 2.45. Found: C, 55.83; H, 7.98; N, 2.29. Complex 2- 15c5 
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is an extremely hygroscopic oil; the high reactivity led to some deviation from the expected 
elemental analysis values. 
 
Figure 2.16 1H NMR spectrum of (15c5NCOPiPr)NiOtBu (2-15c5) in C6D6. 
 
Figure 2.17 31P{H} NMR spectrum of (15c5NCOPiPr)NiOtBu (2-15c5) in C6D6.  
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Figure 2.18 13C{H} NMR spectrum of (15c5NCOPiPr)NiOtBu (2-15c5) in C6D6. 
 
Synthesis of (EtNCOPiPr)Ni(OtBu) (2-Et) 
In a glovebox, a 20 mL vial was charged with 17.0 mg (0.152 mmol) of KOtBu and 2 mL 
of toluene. A solution of 26.2 mg (0.061 mmol) of (EtNCOPiPr)Ni(Br) in 2 mL of toluene was 
added dropwise, and the resulting solution was allowed to stir for 6 h. The solvent was removed 
in vacuo, and the oily residue was extracted with cold pentane (−30 °C) and filtered. The filtrate 
was evaporated to yield a red-orange powder (24 mg, 93% yield). 1H NMR (400 MHz, C6D6): d 
1.17 (dd, 3JHP = 12 Hz, 3JHH = 7 Hz, 6H, CH(CH3)2), 1.36 (s, 9H, Ni−OC(CH3)3), 1.58 (dd, 3JHP 
= 18 Hz, 3JHH = 7 Hz, 6H, CH(CH3)2), 1.62 (t, 3JHH = 7 Hz, 6H, CH2CH3), 1.94 (m, 2H, 
CH2CH3), 2.22 (m, 2H, CH(CH3)2), 3.37 (m, 2H, CH2CH3), 3.54 (s, 2H, ArCH2N), 6.42 (d, 3JHH 
= 7 Hz, 1H, ArH), 6.55 (d, 3JHH = 8 Hz, 1H, ArH), 6.89 (t, 3JHH = 8 Hz, 1H, ArH). 13C {1H} NMR 
(150 MHz, C6D6): d 13.57 (s, CH2CH3), 17.31 (d, 3JCP = 4 Hz, CH(CH3)2), 19.50 (d, 3JCP = 6 Hz, 
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CH(CH3)2), 30.33 (d, 1JCP = 20 Hz, CH(CH3)2), 36.30 (s, Ni−OC(CH3)3), 54.67 (d, 3JCP = 2 Hz, 
CHCH), 63.84 (d, 3J = 2 Hz, ArCHN), 68.38 (s, Ni− OC(CH3)3), 107.00 (d, JCP = 12 Hz, CAr), 
114.15 (d, JCP = 2 Hz), 125.80 (s, CAr), 138.29 (d, 2J = 34 Hz, CAr), 154.54 (s, CAr), 165.90 (d, 
2JCP = 10 Hz, CAr). 31P{1H} NMR (161 MHz, C6D6): d 188.6. Complex 2-Et is extremely 
hygroscopic; the high reactivity confounded characterization by elemental analysis or high-
resolution mass spectrometry. 
 
Figure 2.19 1H NMR spectrum of (EtNCOPiPr)NiOtBu (2-Et) in C6D6.  
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Figure 2.20 31P{H} NMR spectrum of (EtNCOPiPr)NiOtBu (2-Et) in C6D6. 
 
Figure 2.21 13C{H} NMR spectrum of (EtNCOPiPr)NiOtBu (2-Et) in C6D6. 
 58 
 
Synthesis of [(15c5NCOPiPr)Ni(NCCH3)][PF6] (3-15c5) 
In a glovebox, a 20 mL vial covered with foil was charged with 150 µL (2.872 mmol) of 
CH3CN, 49.0 mg (0.193 mmol) of AgPF6, and 3 mL of CH2Cl2. A solution of 102.0 mg (0.176 
mmol) of (15c5NCOPiPr)- Ni(Br) in 1 mL of CH2Cl2 was slowly added to the stirring silver 
solution. After 1 h, 4 mL of pentane was added to the mixture, and the resulting solution was 
filtered. The solvent was removed in vacuo to yield a yellow oil. The oil was washed with 3 × 5 
mL of Et2O to yield a yellow powder (97 mg, 85% yield). 1H NMR (500 MHz, CD2Cl2, −50 °C): 
d 1.29 (dd, 3JHP = 17 Hz, 3JHH = 7 Hz, 6H, CH(CH3)2), 1.33 (dd, 3JHP =17Hz, 3JHH =7Hz, 6H, 
CH(CH3)2), 2.31 (m, 2H, CH(CH3)2), 2.45 (s, 3H, Ni−NCCH3), 3.16 (m, 2H, crown-CH2), 3.35 
(m, 2H, crown-CH2), 3.53 (m, 12H, crown-CH2), 3.96 (s, 2H, ArCH2N), 3.98 (m, 2H, crown-
CH2), 4.61 (m, 2H, crown-CH2), 6.49 (d, 3JHH = 8 Hz, 1H, ArH), 6.64 (d, 3JHH = 7 Hz, 1H, ArH), 
6.99 (t, 3JHH = 8 Hz, 1H, ArH). 13C {1H} NMR (150 MHz, CD2Cl2): d 3.11 (s, Ni−NCCH3), 
16.90 (d, 3JCP = 3 Hz, CH(CH3)2), 17.77 (d, 3JCP = 5 Hz, CH(CH3)2), 28.87 (d, 1JCP = 24 Hz, 
CH(CH3)2), 57.93 (s, crown-CH2), 66.36 (s, ArCH2N), 69.99 (s, crown-CH2), 70.11 (s, crown-
CH2), 70.20 (s, crown-CH2), 72.45 (s, crown-CH2), 109.42 (d, 3JCP = 13 Hz, CAr), 117.13 (d, 4JCP 
= 2 Hz, CAr), 123.74 (s, Ni−NCCH3), 129.17 (s, CAr), 152.80 (s, CAr), 166.19 (d, 2JCP = 9 Hz, 
CAr). Note: the ipso carbon bound to Ni was not observed, perhaps because of broadening of this 
signal due to fluxional acetonitrile binding. 31P{1H} NMR (161 MHz, CD3CN): d −143.4 (sept, 
PF6), 202.7 (s). 31P{1H} NMR (161 MHz, CD2Cl2): d −144.5 (sept, PF6), d 199.12 (s). Note: The 
CH3CN ligand was lost under high vacuum; elemental analysis was calculated for [(κ4-
15c5NCOPiPr)Ni][PF6]. Anal. Calcd for C23H39F6NNiO5P2: C, 42.88; H, 6.10; N, 2.17. Found: C, 
42.78; H, 5.92; N, 2.17. 
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Figure 2.22 1H NMR spectrum of [(15c5NCOPiPr)Ni(NCCH3)][PF6] (3-15c5) in CD2Cl2. 
 
 
Figure 2.23 31P{H} NMR spectrum of [(15c5NCOPiPr)Ni(NCCH3)][PF6] (3-15c5) in CD2Cl2. 
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Figure 2.24 13C{H} NMR spectrum of [(15c5NCOPiPr)Ni(NCCH3)][PF6] (3-15c5) in CD2Cl2. 
 
Figure 2.25 1H NMR spectrum of [(15c5NCOPiPr)Ni(NCCH3)][PF6] (3-15c5) in CD3CN. 
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Figure 2.26 31P{H} NMR spectrum of [(15c5NCOPiPr)Ni(NCCH3)][PF6] (3-15c5) in CD3CN. 
 
Synthesis of [(EtNCOPiPr)Ni(NCCH3)][PF6] (3-Et) 
In a glovebox, a 20 mL vial covered with foil was charged with 34.6 mg (0.137 mmol) of 
AgPF6, 3 mL of CH2Cl2, and 150 µL (2.872 mmol) of CH3CN. A solution of 53.7 mg (0.125 
mmol) of (EtNCOPiPr)Ni(Br) in 2 mL of CH2Cl2 was slowly added to the stirring silver solution. 
After 1 h, 5 mL of pentane was added to the mixture, and the resulting solution was filtered. The 
solvent was removed in vacuo to yield a yellow oil, which was washed with 3 × 5 mL of Et2O to 
yield a yellow powder (65 mg, 97% yield). 1H NMR (600 MHz, CD2Cl2): d 1.36 (dd, 3JHP = 15 
Hz, 3JHH = 7 Hz, 6H, CH(CH3)2), 1.42 (dd, 3JHP = 19 Hz, 3JHH = 7 Hz, 6H, CH(CH3)2), 1.66 (t, 
3JHH = 7 Hz, 6H, CH2CH3), 2.36 (m, 2H, CH2CH3), 2.45 (s, 3H, NCCH3), 2.81 (m, 2H, 
CH(CH3)2), 3.06 (m, 2H, CH2CH3), 4.06 (s, 2H, ArCH2N), 6.52 (d, 3JHH = 8 Hz, 1H, ArH), 6.63 
(d, 3JHH = 8 Hz, 1H, ArH), 7.03 (t, 3JHH = 8 Hz, 1H, ArH). 13C {1H} NMR (150 MHz, C6D6): d 
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3.74 (s, Ni−NCCH3), 13.42 (s, CH2CH3), 16.85 (d, 3JCP = 3 Hz, CH(CH3)2), 17.64 (d, JCP = 5 Hz, 
CH(CH3)2), 28.80 (d, 1JCP = 24 Hz, CH(CH3)2), 56.47 (d, 3JCP = 2 Hz, CH2CH3), 65.12 (d, 3JCP = 
2 Hz, ArCH2N), 109.06 (d, 3JCP = 13 Hz, CAr), 115.80 (d, 4JCP = 2 Hz, CAr), 127.12 (s, 1C, 
Ni−NCCH3), 129.16 (s, CAr), 136.18 (d, 2JCP = 32 Hz, CAr), 154.54 (s, CAr), 166.01 (d, 2JCP = 9 
Hz, CAr). 31P{1H} NMR (242 MHz, CD2Cl2): d −144.49 (sept, PF6), 199.0 (s). Anal. Calcd for 
C19H32F6NiOP2: C, 42.33; H, 5.98; N, 5.20. Found: C, 42.06; H, 5.88; N, 4.97. 
 
Figure 2.27 1H NMR spectrum of [(EtNCOPiPr)Ni(NCCH3)][PF6] (3-Et) in CD2Cl2. 
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Figure 2.28 31P{H} NMR spectrum of [(EtNCOPiPr)Ni(NCCH3)][PF6] (3-Et) in CD2Cl2. 
 
Figure 2.29 13C{H} NMR spectrum of [(EtNCOPiPr)Ni(NCCH3)][PF6] (3-Et) in CD2Cl2.  
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Synthesis of (15c5NCOPiPr)Ni(CH2CN) (4-15c5) 
In a glovebox, a 20 mL vial was charged with 1.5 mL of THF, 3.3 µL (0.063 mmol) of 
CH3CN, and a stirbar. The mixture was frozen at −196 °C, and 36.8 µL (0.059 mmol) of n-BuLi 
(1.6 M in hexanes) was slowly added. The resulting solution was allowed to warm to room 
temperature and was stirred for 20 min. It was then cooled to −30 °C in the glovebox freezer. A 
solution of 28.4 mg (0.049 mmol) of (15c5NCOPiPr)Ni(Br) in THF at −30 °C was then added, and 
the mixture was allowed to warm to room temperature again and stirred for 2 h. The volatiles 
were removed, and the residue was extracted with toluene and filtered. The toluene was removed 
to yield an amber oil (19 mg, 72% yield). 1H NMR (400 MHz, CD2Cl2): d 0.11 (d, 3JHP = 5 Hz, 
2H, Ni−CH2CN), 1.30 (dd, JHP = 14 Hz, JHH = 7 Hz, 6H, CH(CH3)2), 1.38 (dd, JHP = 17 Hz, JHH 
= 7 Hz, 6H, CH(CH3)2), 2.37 (m, 2H, CH(CH3)2), 3.38 (m, 4H, crown-CH2), 3.61 (m, 12H, 
crown-CH2), 4.04 (m, 4H, crown-CH2), 4.35 (s, 2H, ArCH2N), 6.46 (d, 3JHH = 8 Hz, 1H, ArH), 
6.60 (d, JHH = 7 Hz, 1H, ArH), 6.90 (t, JHH = 8 Hz, 1H, ArH). 13C {1H} NMR (150 MHz, 
CH3CN): d −15.16 (d, 3JCP = 12 Hz, Ni−CH2CN), 17.37 (d, 3JCP = 2 Hz, CH(CH3)2), 18.33 (d, 
3JCP = 5 Hz, CH(CH3)2), 28.77 (d, 1JCP = 24 Hz, CH(CH3)2), 58.09 (s, crown-CH ), 68.62 (s, 
ArCH N), 69.86 (s, crown-CH ), 71.15 (s, 222 crown-CH2), 71.28 (s, crown-CH2), 71.57 (s, 
crown-CH2), 107.88 (d, 3JCP = 13 Hz, CAr), 116.08 (s, CAr), 126.41 (s, Ni−CH2CN), 130.87 (s, 
CAr ),148.94 (d, 2JCP =31 Hz, CAr ), 153.27 (s, CAr), 165.28 (d, 2JCP = 10 Hz, CAr). 31P{1H} NMR 
(161 MHz, CD2Cl2): d 196.7. The highly reactive cyanomethyl complex was not suitably stable 
to pass elemental analysis. 
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Figure 2.30 1H NMR spectrum of (15c5NCOPiPr)NiCH2CN (4-15c5) in CD2Cl2. 
 
Figure 2.31 31P{H} NMR spectrum of (15c5NCOPiPr)NiCH2CN (4-15c5) in CD2Cl2. 
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Figure 2.32 13C{H} NMR spectrum of (15c5NCOPiPr)NiCH2CN (4-15c5) in CH3CN. Capillary 
containing C6D6 and HMDSO used to lock and shim. Satellite artifacts near CH3CN/HMDSO 
peak due to field inhomogeneity and receiver overflow. 
 
General Procedure for Nickel-Catalyzed Insertion of Benzaldehyde into a C−H Bond of 
Acetonitrile 
 
In a glovebox, a 20 mL vial was charged with 306 µL (3.0 mmol) of benzaldehyde, 2.5 
mL of acetonitrile, and optional base (e.g., 4.5 µL, 0.03 mmol of DBU). After addition of a 500 
µL aliquot of a solution of 2-15c5 or 3- 15c5 in acetonitrile (0.03 M, 0.015 mmol), the solution 
was capped and allowed to stir at room temperature for 24−120 h. After the desired reaction 
time, a 300 µL aliquot was evaporated to dryness under reduced pressure and dissolved in 
CDCl3, and 6.4 µL (30 µmol) of hexamethyldisiloxane internal standard was added before NMR 
spectroscopic analysis.  
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General Procedure for NMR-Scale Reactions  
In a glovebox, a standard catalytic solution was prepared as described in the general 
procedure. A 600 µL aliquot of the reaction mixture was added to a Teflon-capped NMR tube. 
Most of the reactions were run in protio solvent (CH3CN), so a sealed capillary of C6D6 was 
added to the tube to provide a signal on which to lock and shim. Chemical shifts are reported 
relative to the residual C6D5H signal of the capillary tube. The tube was capped and monitored 
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CHAPTER 3: THERMODYNAMIC STUDIES OF CATION–MACROCYCLE 
INTERACTIONS IN NICKEL PINCER–CROWN ETHER COMPLEXES ENABLE 
SWITCHABLE LIGATION 
 
Reproduced with permission of Smith, J. B.; Kerr, S. H.; White, P. S.; Miller, A. J. M. 
“Thermodynamic Studies of Cation–Macrocycle Interactions in Nickel Pincer–Crown Ether 
Complexes Enable Switchable Ligation.” Organometallics 2017, 36, 3094. Copyright American 




 Control over ligand substitution processes poses a fundamental challenge in coordination 
chemistry and catalysis. Nature achieves impressive temporal control over chemical reactions 
through allosteric regulation.1-2 An active site might be physically inaccessible to substrate until 
a cofactor triggers a structural reorganization that permits substrate binding and initiates 
catalysis. These concepts have been successfully translated to large synthetic supramolecular 
constructs, enabling elegant advances in artificial switchable catalysis.3-7 
 A similar degree of in situ control over ligand binding has not yet been widely realized in 
small organometallic complexes. Modification of a supporting ligand, such as through (de)-
protonation8-9 or binding with a Lewis acid,10-12 can change the electronic structure of the metal 
center and alter substitution rates. Similarly, ligand substitution can be promoted by 
photochemical methods13-14 or redox reagents.15 
 We are targeting in situ control over ligand substitution through tunable hemilability.16 
Hemilabile ligands are chelates with a strong donor to anchor the ligand to the metal center and a 
weak donor that is readily displaced by an incoming ligand.17-21 Ethers are widely used as the 
weak donor in hemilabile complexes, but tuning is usually limited to synthesis of different 
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ligands of varying linker length or substituents.22-26 Our strategy combines design elements of 
hemilabile ligands with the knowledge of metallacrown ether chemistry.27-28 “Pincer−crown 
ether” ligands utilize aza-crown ether macrocycles as hemilabile ether donors, such that ether 
dissociation reveals a macrocycle capable of interacting with cations. 
 
Figure 3.1 Tunable hemilability approach to controlled ligand substitution. The pincer-crown 
ether ligand has a strong donor backbone (blue) and a hemilabile aza-crown ether (orange). If 
ether dissociation by ligand (green) binding (∆Gº1) is uphill, cation-crown interactions can 
stabilize the overall process (∆Gº2).. 
 
 The dual equilibrium approach to tunable hemilability is summarized in Figure 3.1. In 
pincer−crown ether complexes containing a hemilabile ether donor with the pincer ligand bound 
in a tetradentate (κ4) fashion, ligand substitution is often unfavorable (DG°1). Upon ether 
dissociation, the pincer coordination mode switches and the aza-crown ether can better support 
cation−macrocycle interactions, with each cation providing different stability and thus tuning the 
overall binding energy (DG°2).3, 29 By introducing a tunable secondary equilibrium, the free 

































 The promise of tunable hemilability with the pincer−crown ether framework has been 
demonstrated in small molecule activation and catalysis.16 The pentadentate-bound Ir hydride 
complex [k5-(15c5NCOPiPr)Ir(H)][BArF4] (ArF = 3,5-bis-(trifluoromethyl)phenyl) cleaves H2 at a 
rate widely tunable based on the identity of the alkali metal cation and the amount of cation 
present.30 The same Ir hydride cation also catalyzes isomerization of allylbenzene to β-
methylstyrene; in the presence of lithium salts, the rate of catalysis increases 1000-fold.31 This 
approach has recently been utilized by other groups, including in sodium-triggered 
enantioselective hydrogenation by rhodium catalysts bearing aza-crown ether-substituted 
phosphine ligands.32 
 Not all pincer−crown ether complexes show dramatic rate enhancements in the presence 
of cations, however. For example, the cationic methylcarbonyl complex [k3- 
(15c5NCOPiPr)Ir(CH3)(CO)(NCCH3)][BArF4] undergoes cation-accelerated migratory insertion 
reactivity in acetonitrile, but the effects are relatively modest.33 The nickel complex 
(15c5NCOPiPr)Ni(OtBu) catalyzes hydrocyanomethylation of benzaldehyde in CH3CN, and in this 
case, Li+ salts actually inhibit the reaction.34 
 We set out to quantify cation−macrocycle interactions in nickel pincer−crown ether 
complexes and to define the salient design features that enable cation-modulated ligand 
substitution. The role of macrocycle size was probed using a new ligand featuring the larger aza-
18-crown-6 macrocycle, and the role of solvent was clarified through comparative studies in 
dichloromethane and acetonitrile. The thermodynamic studies provide a blueprint for the 
development of systems capable of switchable ligation based on the introduction of a tunable 
secondary equilibrium with appropriate kinetic and thermodynamic parameters. Following this 
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blueprint, a nickel-based system capable of in situ lithium-switchable pentafluorophenylnitrile 
binding was developed. 
3.2 Synthesis and Characterization of Nickel Complexes 
 
 The bromide complex k3-(15c5NCOPiPr)NiBr (1-15c5) was previously reported.34 
Complexes bearing a larger aza-crown ether macrocycle would be expected to have distinct 
binding affinity trends, which could enable a tailored response to specific cations based on the 
thermochemistry of cation−crown interactions in different organometallic complexes. 
 A new ligand was synthesized to access complexes with a larger macrocycle (Scheme 
3.1). Reductive amination of 3-hydroxybenzaldehyde with aza-18-crown-6 was accomplished 
using sodium triacetoxyborohydride (STAB) in THF.33, 35 The aminomethylphenol was treated 
with iPr2PCl and triethylamine (NEt3) to yield (18c6NCOPiPr)H as a colorless oil. 
 
Scheme 3.1 Synthesis of (18c6NCOPiPr)H. 
 
 A Ni complex containing the larger aza-18-crown-6 macrocycle, k3-(18c6NCOPiPr)NiBr 
(1-18c6), was accessed by metalation of (18c6NCOPiPr)H with (DME)Ni(Br)2 (DME is 1,2- 



























Scheme 3.2 Synthesis of 1-15c5 and 1-18c6 
 
 Single crystals of 1-18c6 were grown by slow evaporation of a dilute solution of 1-18c6 
in diethyl ether. The solid-state structure of 1-18c6 (Figure 3.2) showcases tridentate pincer 
binding without any Ni−O interactions, as expected for a d8 metal complex with 16 valence 
electrons. 
 
Figure 3.2 Structural representation of k3-(18c6NCOPiPr)Ni(Br) (1-18c6) with ellipsoids drawn at 
50% probability level. Hydrogen atoms omitted for clarity. Selected distances (Å) and angles 
(deg): Ni–P 2.1096(6), Ni–N 2.028(2), Ni–Br 2.3573(6), Ni–C 1.859(2), P–Ni–Br 94.44(2), P–
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n
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 Addition of lithium trifluoromethanesulfonate (LiOTf) or lithium hexafluorophosphate 
(LiPF6) to the Ni complex 1-15c5 in Et2O resulted in a precipitate. Vapor diffusion of Et2O into 
CH2Cl2 solutions of the compounds provided crystals suitable for X-ray diffraction (XRD) 
analysis. 
 Figure 3.3 shows the LiPF6 adduct of 1-15c5, [(Li+@k3-15c5NCOPiPr)Ni(Br)][PF6] (Li+·1-
15c5). Along with the analogous LiOTf adduct shown in Figure 3.4, these are the first 
structurally characterized cation adducts with this ligand framework. The primary coordination 
sphere of Ni in Li+·1-15c5 is not greatly perturbed relative to 1-15c5. The amine of the aza- 
crown ether remains coordinated only to Ni and does not interact with the Li+ ion. The Li+ ion is 
coordinated by four crown ether oxygen atoms (2.005(8)−2.077(9) Å) and a fluorine atom 
(1.922(5) Å) from the PF6 anion. The Li−O bond lengths are comparable to those in the LiOTf 
adduct of 12-crown-4 (Li−O: 2.053(3)−2.109(4) Å).36 Molybdenum complexes featuring cis-
coordinated R2P(OCH2CH2)3OPR2 ligands with four oxygen donors also have similar Li−O 
bond lengths (2.003−2.195 Å),37-38 whereas a pyridinediimine (PDI) iron complex with a pendent 
15-crown-5 ether has significantly longer Li−O bonds (avg. Li−O 2.20 Å vs 2.05 Å).39 The 
structural similarities suggest that macrocycles with four crown oxygen atoms are good models 
for the binding in Li+·1-15c5. 
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Figure 3.3 Structural representation of [(Li+@k3-15c5NCOPiPr)Ni(Br)][PF6] (Li+•1-15c5) with 
ellipsoids drawn at 50% probability level. Hydrogen atoms omitted for clarity. Selected distances 
(Å) and angles (deg): Ni–P1 2.1099(8), Ni–N 2.046(2), Ni–Br 2.3584(8), Ni–C 1.860(3), avg. 




Figure 3.4 Structural representation of [(Li+@k3-15c5NCOPiPr)Ni(Br)][OTf] (LiOTf•1-15c5) with 
ellipsoids drawn at the 50% probability level. Hydrogen atoms omitted for clarity. Selected 
distances (Å) and angles (deg): Ni–P 2.108(1), Ni–N 2.046(2), Ni–Br 2.360(1), Ni–C 1.857(4), 




 The solid-state structure of the sodium adduct [(Na+@ k3-15c5NCOPiPr)Ni(Br)][BArF4] 
(Na+·1-15c5) was also determined. Crystals suitable for XRD analysis were grown by vapor 
diffusion of pentane into a Et2O solution containing 1-15c5 and 2 equiv NaBArF4 at −30 °C 
(Figure 3.5). The Na+ ion in Na+·1-15c5 has a distorted octahedral geometry and is facially 
coordinated by only three of the four oxygen atoms of the crown ether. The Na−O bond lengths 
are similar to the 2:1 12-crown-4 complex with Na+ and the 1:1 15-crown-5 complex of Na+.40-41 
Organometallic complexes with 15-crown-5 or polyether ligands also have similar Na−O 
distances.39, 42 However, the Na+ ion in Na+·1-15c5 sits well outside of the center of the crown 
ether cavity and the conformation of the crown allows Na+ to interact with an Et2O molecule, a 
fluorine of the BArF4 counterion, and even the bromide ligand attached to the Ni center. Crown 
ethers can adopt a wide range of geometries in order for alkali metal guests to participate in 
stabilizing secondary interactions with solvent molecules or halogen atoms.43 The structural 
differences between the Li+ and Na+ adducts of 1-15c5 suggest that the binding affinity for each 
cation will be different. 
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Figure 3.5 Structural representation of [(Na+@k3-15c5NCOPiPr)Ni(Br)][BArF4] (Na+•1-15c5) with 
ellipsoids drawn at 50% probability level. Hydrogen atoms omitted for clarity. Selected distances 
(Å) and angles (deg): Ni–P 2.1065(8), Ni–N 2.047(2), Ni–Br 2.3572(5), Ni–C 1.862(3), avg. Na–
Ocrown 2.41, Na–O2 2.319(2), Na–FBArF4 2.612(2), Na-Br 2.814(1), P–Ni–Br 92.78(2), P–Ni–C 
81.18(8), N–Ni–Br 102.53(6), N–Ni–C 84.6(1). 
 
 Pincer−crown ether Ni complexes were previously studied in acetonitrile, where solvent 
displacement of the macrocyclic ether donors prevents hemilability.34 In CH2Cl2, halide 
abstraction from 1-15c5 or 1-18c6 by addition of AgPF6 results in AgBr precipitation and 
formation of the tetradentate-bound complexes [κ4-(15c5NCOPiPr)Ni][PF6] (2-15c5) and [κ4- 
(18c6NCOPiPr)Ni][PF6] (2-18c6), each containing one crown ether oxygen atom donating to Ni 
(Scheme 3.3).  
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Scheme 3.3 Synthesis of 2-15c5 and 2-18c6. 
 
 Vapor diffusion of Et2O into a CDCl3 solution of 2-15c5 provided crystals suitable for 
XRD analysis. The solid-state structure of 2-15c5 (Figure 3.6) confirms the tetradentate 
coordination mode of the ligand, in which one crown ether oxygen is bound to the Ni center. The 
Ni system can readily support either tridentate (1-15c5) or tetradentate (2-15c5) transition metal 
binding, as needed for crown ether hemilability. The distorted square planar geometry, with C1 
symmetry and all donors in the same plane, contrasts with Ir complexes that adopt a mer,fac 
configuration when a crown ether oxygen binds to give tetradentate ligand coordination in an 









n = 1, 1-15c5













n = 1, 2-15c5




Figure 3.6 Structural representation of [k4-(15c5NCOPiPr)Ni][PF6] (2-15c5) with ellipsoids drawn 
at the 50% probability level. Hydrogen atoms and PF6 anion omitted for clarity. Selected 
distances (Å) and angles (deg): Ni–P 2.1427(6), Ni–N 1.966(2), Ni–O 1.965(2), Ni–C 1.848(2), 
P–Ni–O 110.34(4), P–Ni–C 81.32(6), N–Ni–O1 83.94(6), N–Ni–C1 84.60(8), C1–Ni–O1 
167.36(7). 
 
 The 1H NMR spectra of 2-15c5 and 2-18c6 are consistent with Cs symmetry in solution at 
room temperature. The resonances of 2-15c5 and 2-18c6 are sharp at room temperature, but they 
broaden upon cooling to −80 °C without completely decoalescing, suggesting a low barrier for 
ligand exchange (Figures 3.7 and 3.8). The spectral data are consistent with dynamic hemilability 













Scheme 3.4 Dynamic hemilability of 2-15c5 and 2-18c6. 
 
 In order to avoid LiPF6 precipitation during subsequent studies, an anion exchange was 
performed on 2-15c5. The PF6 salt 2-15c5 is treated with NaBArF4 in CH2Cl2 to form [κ4- 
(15c5NCOPiPr)Ni][BArF4] (3-15c5). The spectroscopic signatures of 3-15c5 were completely 
analogous to 2-15c5, indicating a similar structure. 
 Isolation of complexes 1 and 2 confirms that the pincer−crown ether ligand can act as a 
hemilabile ligand on nickel complexes, with facile access to two different pincer ligand 
coordination modes in noncoordinating solvents. The structural studies provide direct evidence 
of cation−crown interactions in the solid state. 
3.3 Cation–Crown Interactions in Dichloromethane 
 
 To learn more about the thermochemistry of cation−macrocycle interactions in nickel 
pincer−crown ether complexes, cation binding affinity data in solution were targeted. Titration of 
the small macrocycle-containing bromide complex 1-15c5 with LiBArF4 in CD2Cl2 (15 equiv 
Et2O to salt) led to the broadening and shifting of 1H NMR resonances expected for a rapid 
equilibrium process (Figure 3.9). Signals corresponding to the isopropyl methyl protons did not 
shift significantly during these experiments, and only small shifts were observed in the isopropyl 
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corresponding to the crown ether exhibited the largest shifts (Ddmax = 0.62), indicating a 
host−guest interaction localized in the macrocycle of the complex. 
 
Figure 3.9 A) 1H NMR spectra from titration of 5 mM k3-(15c5NCOPiPr)Ni(Br) (1-15c5) with 
LiBArF4 in CD2Cl2 (15 equiv Et2O to Li+). B) Cation binding isotherm data for the titration of 5 
mM 1-15c5 with LiBArF4 (green circles) at 20 ± 1 ºC in CD2Cl2 (15 equiv Et2O to cation). 
 
 Plotting the change in chemical shift (Dd) of the benzylic linker or crown ether 
resonances as a function of added cation gives binding isotherms that plateau sharply at 1 equiv 
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of salt with respect to Ni. The data indicate strong cation binding by 1-15c5, which lacks any 
Ni−O interactions. Under these conditions, Li+ binding occurs with Ka > 105 M−1 (DG° > 7 
kcal·mol−1), beyond the upper limit of quantification for NMR titration studies.44-45 
 
Figure 3.10 Cation binding isotherm data for the titration of 5 mM k3-(15c5NCOPiPr)NiBr (1-
15c5) with LiBArF4 (filled green circles) and NaBArF4 (filled blue triangles) and 5 mM k3-
(18c6NCOPiPr)NiBr (1-18c6) with LiBArF4 (hollow green circles) and NaBArF4 (hollow blue 
triangles) at 20 ± 1 ˚C in CD2Cl2 (15 equiv Et2O to cation). 
 
 Similar binding isotherms were obtained with NaBArF4 (Figure 3.10, 15 equiv Et2O to 
salt), in accord with strong cation binding (Ka > 105 M−1). Partial halide abstraction complicated 
NaBArF4 titrations of 1-15c5, however. In tubes with higher salt concentrations, up to 40% 
















Figure 3.11 1H NMR spectra from the titration of 5 mM k3-(15c5NCOPiPr)NiBr (1-15c5) with 
NaBArF4 with 1H NMR spectrum of [k4-(15c5NCOPiPr)Ni][BArF4] (3-15c5) at top of stack for 
reference.  
 
 The larger aza-18-crown-6-containing bromide complex 1-18c6 also exhibits strong 
binding (Ka > 105 M−1) of both LiBArF4 and NaBArF4 based on titration studies in CD2Cl2 
(Figure 3.10, Scheme 3.5). Interestingly, no halide abstraction from 1-18c6 was observed during 
titrations with Na+, indicating a thermodynamic preference for cation−crown interactions over 
formation of the NaBr lattice. Indeed, when 2-18c6 is added to a suspension of NaBr in CD2Cl2 
with 100 mM Et2O, signals for Na+·1-18c6 are observed.46 The analogue containing a smaller 
macrocycle, 3-15c5, did not react with NaBr to form a Ni bromide complex.46 
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Scheme 3.5 Equilibrium Li+ and Na+ Binding by 1-15c5 and 1-18c6 in CD2Cl2. 
 
 The tetradentate-bound BArF4 salt 3-15c5 does not bind Li+ to any significant extent. 
Upon addition of up to 3 equiv LiBArF4·3Et2O to CD2Cl2 solutions of 3-15c5, the 1H NMR 
resonances of the crown ether protons did not shift (Figure 3.12). The Li+ binding affinity of 3-
15c5 is less than 1 M−1 in CD2Cl2. 
 
Figure 3.12 Addition of 1-3 equivalents of LiBArF4•3Et2O to [k4-(15c5NCOPiPr)Ni][BArF4] (3-
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 When one of the crown ether oxygen atoms is bound to the nickel center, as in 
tetradentate-bound complex 3-15c5, interactions with alkali metal cations are negligible. In the 
case of complex 1-15c5, all four ether donors are available for cation binding, leading to a 
striking coordination-mode- dependent binding affinity. When the hemilabile ligand switches 
from tetradentate to tridentate coordination allowing all four ether donors to participate in 
host−guest interactions, cation binding becomes more than 100,000 times more favorable. This 
difference suggests a large energetic stabilization will be possible upon ligand binding in the 
presence of cations. Organic macrocycles with different numbers of available oxygen donors 
sometimes show large changes in binding affinity. For example, calorimetric titrations in 
acetonitrile show that barium cations bind to 12-crown-4 about 13,000 times more strongly than 
they bind to 9-crown-3.47 
 The titration data for Ni complexes ligated in a tridentate fashion also provide insight into 
the dynamics of cation−crown interactions in catalysis. The plateau at a cation:complex ratio of 1 
indicates a 1:1 binding stoichiometry. The titrations indicate that cation−macrocycle binding is 
rapid and reversible on the time scale of the NMR acquisition. Maintaining low barriers of cation 
exchange could be important in supporting rapid catalysis. Additionally, these experiments 
suggest that cation−crown interactions can offset uphill substrate binding (DG°1, Figure 3.1) by 
at least 7 kcal·mol−1 (based on the limiting value of Ka > 105 M−1 in CD2Cl2). 
3.4 Cation–Crown Interactions in Acetonitrile 
 
 Titrations in dichloromethane indicate that both Li+ and Na+ are bound tightly by 1-15c5 
and 1-18c6, but quantitation of cation selectivity was elusive. The more polar, donor solvent 
acetonitrile was expected to temper binding affinities enough to allow quantitative measurement 
of cation binding by 1H NMR spectroscopy. Moving to acetonitrile also allows direct 
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comparisons with many organic macrocycles48-50 and provides better alkali metal salt solubility 
to improve precision in titrations. 
 Preliminary 1H NMR studies showed that addition of either Li+ or Na+ salts to 1-15c5 in 
CD3CN caused significant broadening and systematic shifts in resonances corresponding to the 
crown ether and benzylic linker protons without evidence of formation of two distinct species on 
the 1H NMR time scale. This behavior is consistent with rapid and reversible equilibrium 
cation−crown interactions on the 1H NMR time scale at room temperature. In contrast to the 
CD2Cl2 titrations, these resonances continued to shift even as the cation:Ni ratio increased above 
1, suggesting weaker —and quantifiable— binding in CD3CN. Interactions were also evident in 
electrospray ionization mass spectrometry (ESI−MS), where Li+·1-15c5 (m/z calcd 586.12; 
found 586.22) and Na+·1-15c5 (m/z calcd: 602.10; found 602.15) were observed. 
 In order to obtain quantitative binding affinity data, a model that takes into account the 
binding stoichiometry is needed. Using the method of continuous variations (MCV),51 the change 
in chemical shift of the benzylic linker of 1-15c5 in solutions containing varying amounts of 
LiOTf (maintaining a total concentration of 12 mM) was used to construct a Job plot (Figure 
3.13). The maximum at 0.5 mole fraction Li+ indicates a 1:1 binding stoichiometry. A similar 
experiment with 1-15c5 and NaBArF4 was also consistent with 1:1 binding stoichiometry. 
Attempts to obtain the binding stoichiometry for 1-15c5 and K+ were unsuccessful because the 
changes in chemical shift were unreliably small (indicating quite weak interactions). As shown in 
Figure 3.13, 1-18c6 also exhibits 1:1 binding stoichiometry with all three alkali metal salts. 
 90 
 
Figure 3.13 Job plots for k3-(15c5NCOPiPr)Ni(Br) (1-15c5) with LiOTf (hollow green circles) and 
NaBArF4 (hollow blue triangles), and Job plots for k3-(18c6NCOPiPr)Ni(Br) (1-18c6) with LiOTf 
(filled green circles), NaBArF4 (filled blue triangles), and KPF6 (filled orange squares) at 24 ± 
1˚C in CD3CN. Concentrations of 1-15c5 or 1-18c6 and cations were varied within a total 
concentration of 12 mM. 
 
 Binding affinities were next determined by titration of CD3CN solutions of Ni complexes 
with increasing amounts of LiOTf. Resonances corresponding to the crown ether and benzylic 
linker protons broadened and smoothly shifted as the concentration of Li+ increased. The 
nonlinear changes in chemical shift and the leveling off of the binding isotherm at a Li+:Ni ratio 
of 8 are appropriate for quantitative modeling (Figure 3.14).45, 52 Fitting the binding isotherm 
with a 1:1 model gave Ka = 91 M−1 for LiOTf. A similar experiment was performed with LiPF6 





























Figure 3.14 A) Cation binding equilibrium in CD3CN. B) 1H NMR spectra from titration of 10 
mM k3-(15c5NCOPiPr)Ni(Br) (1-15c5) with LiOTf in CD3CN. C) Binding isotherm data for 
titration of 10 mM k3-(15c5NCOPiPr)Ni(Br) (1-15c5) with LiPF6 (green circles), NaBArF4 (blue 
triangles), and KPF6 (orange squares) at 24 ± 1˚C in CD3CN. 
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Figure 3.15 Binding isotherm data for titration of 10 mM k3-(15c5NCOPiPr)Ni(Br) (1-15c5) with 
LiPF6 at 24 ± 1˚C in CD3CN. 
 
 Titration of 1-15c5 with NaBArF4 or KPF6 gave small chemical shifts and nearly linear 
binding isotherms that do not appear to approach a maximum Dd value within the limits of salt 
solubility. Consistent with the MCV analysis, the data suggest that 1-15c5 does not interact 
strongly with Na+ or K+ under these conditions, Ka < 10 M−1. 
 Simply changing the solvent from dichloromethane to acetonitrile results in a decrease in 
binding affinity of at least 3 orders of magnitude! The solvent-dependent binding affinity 
provides some insight into previously observed solvent effects in cation-tuned organometallic 
transformations of pincer− crown ether complexes. Whereas 1,000-fold rate enhancements have 
been observed in CH2Cl2 solution,30 only moderate cation effects have been observed for 
reactions facilitated by pincer−crown ether complexes in acetonitrile solvent.33-34 The decrease in 
binding affinity moving from CH2Cl2 to CH3CN may be partially responsible for the smaller 
















Figure 3.16 Titration of 10 mM k3-(EtNCOPiPr)Ni(Br) with LiPF6 at 24 ± 1˚C in CD3CN. 
 
The macrocyclic pincer ligand is essential for fostering the observed interactions with 
cations. An identical titration experiment performed with k3-(EtNCOPiPr)Ni(Br), which contains 
ethyl substituents in place of the aza-crown ether, showed negligible broadening or shifting 
(Figure 3.16). Treatment of 1-15c5 with 10 equiv [Bu4N][PF6] did not result in any perceptible 















Figure 3.17 Binding isotherm data for titration of 10 mM k3-(18c6NCOPiPr)Ni(Br) (1-18c6) with 
LiPF6 (green circles), NaBArF4 (blue triangles), and KPF6 (orange squares) at 24 ± 1˚C in 
CD3CN. 
 
 It is well-known that the size of the crown ether macrocycle (i.e., number of ether donors) 
has a dramatic effect on cation binding affinity.49-50, 53-55 To probe whether similar trends would 
hold in our organometallic complexes, the alkali metal cation binding affinity of 1-18c6 
(containing the larger aza-18-crown-6 macrocycle) was determined in CD3CN using the titration 
methods described above (Figure 3.17 and Table 3.1). The equilibrium constant for Li+ binding 
by 1-18c6 (Ka = 34 M−1) is somewhat smaller than that of 1-15c5. The affinity of 1-18c6 for the 
Na+ salt, on the other hand, was quite high: Ka = 1490 M−1 is the highest cation binding affinity 
we measured in CD3CN. Due to the high binding affinity of 1-18c6 with Na+, the titration was 
performed at three different concentrations of 1-18c6 to confirm Ka within 6% uncertainty.46, 56 
The binding affinity of 1-18c6 with K+, Ka = 60 M−1, indicates significant cation−crown 






















Table 3.1 Association Constants in CD3CN. 
 
Complex Salt Ka (M-1) 
1-15c5 LiPF6 76 
 LiOTf 91 
 NaBArF4 < 10 
 KPF6 < 10 
1-18c6 LiPF6 34 
 NaBArF4 1260 
 KPF6 60 
Conditions: CD3CN, 10 mM 1, 0-120 mM salt. Analyzed by 1H NMR spectroscopy at 24 ± 1˚C. 
Estimated uncertainty ≤ 10%. 
 
3.5 Comparisons with Organic Crown Ethers and Variable Temperature Studies  
 
 Extensive binding affinity data is available for organic crown ethers in acetonitrile, 
facilitating comparisons between organometallic and organic systems in this solvent. Because all 
structural and spectroscopic evidence suggests that the amine nitrogen remains bound to the 
transition metal center under the present experimental conditions, we considered the four-
oxygen-donor 12-crown-4 a good starting point for comparisons with aza-15-crown-5- derived 
organometallic complexes. 
 The organic macrocycle 12-crown-4 binds Li+ with modest selectivity. In CH3CN 
solution, Li+ ions bind to 12-crown-4 1.2 times more tightly than Na+ ions.48 The same trend in 
cation specificity is observed for the aza-15-crown-5-containing pincer−crown ether complex, 
with 1-15c5 preferentially binding Li+ over Na+ and K+. Surprisingly, the organometallic 
macrocycle exhibits more selective Li+ binding than 12-crown-4: 1-15c5 binds Li+ greater than 7 
times more tightly than Na+ in CH3CN. 
 Moving from 12-crown-4 to 15-crown-5 leads to a change in cation selectivity, with the 
larger macrocycle 15-crown-5 selectively binding Na+ ions. The same general trend is observed 
in Ni complexes with the larger aza-18-crown-6 macrocycle, as 1-18c6 selectively binds Na+ 
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ions over Li+ or K+ ions. Complex 1-18c6 binds Na+ 44-times more strongly than Li+ and 25-
times more strongly than K+. Again, the Ni complex is more selective for Na+ than the analogous 
organic macrocycle; 15-crown-5 has an equilibrium constant for Na+ binding that is only 6−8 
times larger than for Li+ and K+.48 
 The Ni complexes bind cations orders of magnitude less strongly than similar organic 
crown ethers. Both 12-crown-4 and 1-15c5 present the same array of four oxygen donors, but 12- 
crown-4 binds Li+ with Ka = 2512 M−1, nearly 40 times higher than that of 1-15c5.48 Similarly, 
five-oxygen donor 15-crown-5 binds Na+ (Ka = 126 000 M−1) 85 times more tightly than five- 
oxygen donor 1-18c6 (Ka = 1490 M−1).48 
 
Figure 3.18 Binding isotherm data for titration of 0.01 M k3-(15c5NCOPiPr)Ni(Br) (1-15c5) with 
LiOTf in CD3CN at various temperatures (left) and binding isotherm data for titration of 0.01 M 
k3-(18c6NCOPiPr)Ni(Br) (1-18c6) with NaBArF4 in CD3CN at various temperatures (right). 
 
 To probe the origin of the large differences in binding affinity between organic and 
organometallic macrocycles, the enthalpy and entropy of binding were determined. 











































on the basis of variable-temperature NMR experiments using a van ‘t Hoff analysis (Figure 10). 
Six tubes containing 10 mM Ni and increasing equivalents of Li+ or Na+ salts were prepared, and 
Ka was determined every 10 degrees from 253 to 293 K. 
 
Figure 3.19 Van ‘t Hoff analysis of LiOTf binding by k3-(15c5NCOPiPr)Ni(Br) (1-15c5) (green 
circles) and NaBArF4 binding by k3-(18c6NCOPiPr)Ni(Br) (1-18c6) (blue triangles). 
 
 Thermodynamic analysis of Li+ ion binding by 1-15c5 reveals an enthalpy-driven process 
(DH = −2.50 ± 0.46 kcal·mol−1) with a negligible entropic term (DS = 0.0 ± 1.7 cal·mol−1·K−1). 
A comparison with 12-crown-4 under similar conditions is shown in Table 3.2. Both 
macrocycles have small entropy terms, so the difference in binding affinity can be ascribed to 
reduced enthalpy of Li+ binding to the Ni complex. This could be due to conformational 
restrictions reducing bonding interactions or inductive effects from the electropositive Ni center 
pulling electron density out of the crown ether. Inductive effects have been invoked in benzyl-























M−1) nearly 2 full orders of magnitude stronger than the p-nitro- substituted compound (Ka = 
9300 M−1).57 Similarly, electronic effects seemed to dominate in a study of crown ethers that link 
the oxygen atoms with linkers of variable length and electronic structure (alkyl vs acetyl).58 
 Na+ binding by 1-18c6 is also enthalpy-driven (DH = −5.10 ± 0.46 kcal·mol−1), with a 
relatively small entropic contribution (DS = −2.6 ± 1.7 cal·mol−1·K−1). The binding enthalpy is 
significantly more favorable than 1-15c5 and Li+, consistent with the pair 1-18c6 and Na+ 
exhibiting the highest binding affinity of all the pincer−crown ether complexes and alkali metal 
cations in CH3CN at 24 ± 1 °C. The organic crown ether 15-crown-5 binds Na+ with enthalpy 
and entropy terms that are both slightly more favorable than 1-18c6 (Table 3.2). 
Table 3.2 Thermodynamic Parameters in CD3CN. 
 
Macrocycle Salt DH (kcal·mol–1) DS (cal·mol–1·K–1) TDS (kcal·mol
–1) 
at 298 K Ref. 
1-15c5a LiOTf –2.50 ± 0.46 0.0 ± 1.7   0.00 this work 
12-crown-4 LiOTf –5.18 –1.1 –0.33 Danil et al.58 
1-18c6a NaBArF4 –5.10 ± 0.46 –2.6 ± 1.7 –0.76 this work 
15-crown-5 NaBPh4 –6.2 +2.4 +0.7 Okorafor et al.59 
a Parameters determined in CD3CN by van ‘t Hoff analysis of variable temperature NMR 
titrations at 253, 263, 273, 283, and 293 K. 
 
3.6 Cation Switchable Ligand Binding 
 
 With a deep understanding of cation−macrocycle interactions in nickel pincer−crown 
ether complexes, we set out to demonstrate control over ligand substitution. Tetradentate-bound 
Ni complex 3-15c5 could block ligand access to the site trans to the phenyl backbone through 
interaction with a crown ether oxygen atom, whereas a tridentate analogue formed after ligand 
binding and ether dissociation could support cation−crown interactions. The effect of alkali 
metal salts on pentafluorobenzonitrile (C6F5CN) binding at 3-15c5 was examined. 
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 The tetradentate-bound complex 3-15c5 does not bind C6F5CN in CD2Cl2. Displacement 
of the weakly bound ether in 3-15c5 by either solvent CD2Cl2 or Lewis base C6F5CN is 
unfavorable. The ether donor thus acts as an effective “gate” for ligand binding. 
 
Scheme 3.6 Reversible C6F5CN binding by 3-15c5. 
 
 Addition of K+ to a solution containing 3-15c5 and C6F5CN in CD2Cl2 had no discernible 
effect within the limits of KB(C6F5)4 solubility. No K+-triggered ligation is observable. On the 
other hand, addition of Na+ to a solution containing 3-15c5 and C6F5CN results in equilibrium 
nitrile binding as indicated by broadening and shifting of the resonances of the 1H NMR 
spectrum (Figures 3.20, 3.21, and 3.22). Two sets of broad resonances are observed in 31P{1H} 
and 19F{1H} NMR spectra, reflecting roughly 70% 3-15c5 and 30% of a species assigned as the 









































Figure 3.20 1H NMR spectra from sequential addition of 1 equivalent C6F5CN and 
[K][B(C6F5)4] to [k4-(15c5NCOPiPr)Ni][BArF4] (3-15c5) in CD2Cl2 (top to bottom). 
 
 
Figure 3.21 31P NMR spectra from sequential addition of 1 equivalent C6F5CN and 




Figure 3.22 19F NMR spectra from sequential addition of one equivalent C6F5CN and 
[K][B(C6F5)4] to [k4-(15c5NCOPiPr)Ni][BArF4] (3-15c5) in CD2Cl2 (top to bottom). 
 
Figure 3.23 1H NMR spectra from sequential addition of 1 equivalent C6F5CN, 1 equivalent 
NaBArF4, and 2 equivalents 12-crown-4 to [k4-(15c5NCOPiPr)Ni][BArF4] (3-15c5) in CD2Cl2 (15 




Figure 3.24 31P{1H} NMR spectra from sequential addition of 1 equivalent C6F5CN, 1 
equivalent NaBArF4, and 2 equivalents 12-crown-4 to [k4-(15c5NCOPiPr)Ni][BArF4] (3-15c5) in 
CD2Cl2 (15 equivalents Et2O to Na+ added for solubility) (top to bottom). 
 
 
Figure 3.25 19F NMR spectra from sequential addition of 1 equivalent C6F5CN, 1 equivalent 
NaBArF4, and 2 equivalents 12-crown-4 to [k4-(15c5NCOPiPr)Ni][BArF4] (3-15c5) in CD2Cl2 (15 
equivalents Et2O to Na+ added for solubility) (top to bottom). 
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 Upon addition of 1 equiv Li+ to a CD2Cl2 solution containing 3-15c5 and C6F5CN, 
complete conversion to a new species is observed (Scheme 3.6). 7Li NMR spectra confirm that 
Li+ is tightly bound to the nickel pincer−crown ether complex,46 and 19F{1H} NMR spectra 
indicate stoichiometric nitrile binding based on a dramatic downfield shift in the para-F 
resonance of C6F5CN (Figures 3.26, 3.27, and 3.28).59-60 The spectrum is not fluxional in this 
case; the equilibrium for ligand binding lies far toward nitrile ligation. The macrocyclic “gate” 
can thus be fully opened with the aid of Li+ binding. 
 
Figure 3.26 1H NMR spectra from sequential addition of 1 equivalent C6F5CN, 1 equivalent 
LiBArF4•3Et2O, and 2 equivalents 12-crown-4 to [k4-(15c5NCOPiPr)Ni][BArF4] (3-15c5) in 




Figure 3.27 31P NMR spectra from sequential addition of 1 equivalent C6F5CN, 1 equivalent 
LiBArF4•3Et2O, and 2 equivalents 12-crown-4 to [k4-(15c5NCOPiPr)Ni][BArF4] (3-15c5) in 
CD2Cl2 (top to bottom). 
 
 
Figure 3.28 19F NMR spectra from sequential addition of 1 equivalent C6F5CN, 1 equivalent 
LiBArF4•3Et2O, and 2 equivalents 12-crown-4 to [k4-(15c5NCOPiPr)Ni][BArF4] (3-15c5) in 
CD2Cl2 (top to bottom). 
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 The titration data above suggest that Li+ forms a stronger adduct with 12-crown-4 than 
with 3-15c5 in acetonitrile, so we hypothesized that the organic crown could be used to reverse 
nitrile binding in dichloromethane. After Li+-triggered nitrile binding to Ni, addition of 2 equiv 
12-crown-4 leads to rapid sequestration of Li+, with release of free C6F5CN and reformation of 3-
15c5 apparent by NMR spectroscopy (Scheme 3.6 and Figures 3.26, 3.27, and 3.28). Similar 
behavior is observed in equilibrium mixtures formed upon addition of Na+ and C6F5CN to 3-
15c5: addition of 12-crown-4 leads to sharp signals for 3-15c5 and the 1H resonances of 12-
crown-4 shift downfield indicating Na+ complexation. Cation-controlled in situ switchable ligand 




 A quantitative understanding of the interactions of alkali metal cations with 
pincer−crown ether complexes has enabled the development of a nickel complex wherein 
cation−crown interactions in the secondary coordination sphere regulate ligand binding in the 
primary coordination sphere. 
 The information gleaned from mechanistic studies provides a blueprint for designing 
systems capable of controllable ligand substitution. The tunable energy landscape is provided by 
equilibrium dissociation of a hemilabile chelate to form a partially dissociated ligand state that 
engages in a tunable second equilibrium. Any number of secondary interactions, such as 
hydrogen bonding or π−π stacking interactions, could theoretically be used. In the present case, 
the aza-crown ether macrocycle provides hemilabile ether ligands that support strong 
cation−crown interactions in their dissociated state, as illustrated in Figure 3.1. 
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 Several thermodynamic factors control ligand binding. Thermodynamically, 
displacement of the weak donor of the hemilabile chelate by a substrate must be unfavorable in 
the absence of an external stimulus; the chelating “gate” must remain closed until the appropriate 
additive is present. Conversely, the secondary equilibrium should be thermodynamically 
favorable. When the energetics of the two equilibria are matched, ligand binding is rendered 
favorable by strong cation−crown interactions. Titrations indicate that Li+ or Na+ binding to 
tridentate-bound pincer−crown ether species can provide more than 7 kcal·mol−1 of stabilization 
in dichloromethane. Finally, tunable ligand binding is possible only when the dissociated state of 
the ligand interacts with cations more strongly than the fully bound state. Alkali metal cations 
have negligible interactions with the tetradentate-bound complexes in which a crown oxygen 
atom is donating to the metal center, leading to preferential stabilization of the tridentate-bound 
species present when a substrate binds. 
 Solvent choice is also key to the effectiveness of this strategy. Dichloromethane is an 
ideal choice for cation-promoted reactivity. It is sufficiently polar to dissolve salts (albeit with 
lipophilic, weakly coordinating anions) and it is sufficiently noncoordinating that cation−crown 
interactions are strong (Ka > 105 M−1) relative to cation−solvent interactions. Dichloromethane 
also facilitates hemilability by avoiding solvent displacement of the weak crown ether donors. 
On the other hand, previous work demonstrated that the polar, coordinating solvent acetonitrile 
displaces ethers bound to the transition metal in complex 2-15c5 to form the acetonitrile 
adduct,34 disrupting ligand hemilability and preventing control over substrate binding. 
Cation−crown interactions are also weaker in acetonitrile, limiting the stabilization of tridentate-
bound Ni species to less than 4.3 kcal·mol−1. 
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 The foregoing findings help identify ideal conditions for future systems. Weakly 
coordinating solvents will be preferred because they enforce strong, highly stabilizing 
cation−crown interactions. Li+ is a promising regulator of catalysts containing the aza-15-crown-
5 macrocycle, but Na+ is predicted to be more effective for catalysts containing the aza-18-
crown-6 macrocycle. 
3.8 Experimental Section 
 
General Considerations 
 Standard vacuum line and glovebox techniques were utilized to maintain a N2 atmosphere 
during manipulation of all compounds, unless otherwise noted. Organic solvents were dried and 
degassed with argon using a Pure Process Technology solvent system and stored over 3 Å 
molecular sieves. Under standard glovebox operating conditions, pentane, diethyl ether, benzene, 
toluene, and tetrahydrofuran were used without purging, so traces of those solvents might be 
present in the atmosphere and in the solvent bottles. 1H, 31P, 19F, and 13C NMR spectra were 
recorded on 400, 500, or 600 MHz spectrometers. NMR spectroscopic characterization data are 
reported at 25 °C, unless specified otherwise. All NMR solvents were purchased from 
Cambridge Isotope Laboratories. Acetonitrile-d3 (CD3CN), benzene-d6 (C6D6), chloroform-d 
(CDCl3), and methylene chloride-d2 (CD2Cl2) were freeze−pump−thaw-degassed three times, 
dried by passage through a small column of activated alumina, and stored over 3 Å molecular 
sieves. 1H and 13C chemical shifts (d) are reported in parts per million relative to residual protio 
solvent resonances. All 31P resonances are reported relative to 85% H3PO4 external standard (d 
0). The following compounds were synthesized according to literature procedures: 
(15c5NCOPiPr)H,30 NaBArF4,61 LiBArF4•3Et2O,30 k3-(15c5NCOPiPr)Ni(Br),34 and k3-
(EtNCOPiPr)Ni(Br).62 LiOTf was dried under reduced pressure at 100 ˚C for 24 h prior to storage 
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in a N2 glovebox. All other reagents were commercially available and used without further 
purification.  
 Elemental analyses were performed by Robertson Microlit Laboratories (Ledgewood, 
NJ). Mass spectrometry was carried out with an LTQ FT (ICR 7T) (ThermoFisher, Bremen, 
Germany) mass spectrometer. Samples (in acetonitrile solution) were introduced via a micro- 
electrospray source at a flow rate of 3 µL/min. Xcalibur (Thermo-Fisher, Breman, Germany) was 
used to analyze the data. 
 Single-crystal X-ray diffraction data were collected on a Bruker Smart Apex-II 
diffractometer at 100 ± 2 K with Cu Kα radiation (λ = 1.54175 Å). Diffraction profiles were 
integrated using the SAINT software program. Absorption corrections were applied using 
SADABS. Using Olex 2,63 the structure was solved using SHELXS64 direct methods and refined 
using the XL65 refinement package via the least-squares method. Hydrogen atoms were 
generated theoretically and refined isotropically with fixed thermal factors. 
Synthetic Procedures 
Synthesis of m-(Aza-15-crown-5)methylphenol 
 A 200 mL Schlenk flask was charged with 0.849 g (6.952 mmol) 3-
hydroxybenzaldehyde, 1.016 g (4.635 mmol) 1-aza-15-crown-5, and 35 mL THF. The mixture 
was allowed to stir for one hour and then 1.96 g (9.248 mmol) sodium triacetoxyborohydride 
was added in 0.5 g increments every ~6 hours. The reaction was stirred for an additional 24 
hours and then quenched with aqueous saturated NaHCO3. The product was extracted into 4 x 25 
mL of CH2Cl2 and the solvent of the combined extracts was removed. The crude product was 
purified using a short silica plug. Unreacted aldehyde and the byproduct 3-hydroxymethylphenol 
were eluted with a 60/40 (% v/v) CH2Cl2/EtOAc mobile phase until TLC showed no remaining 
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traces of alcohol. The product was then eluted with an 85/10/5 (% v/v/v) CH2Cl2/NEt3/MeOH 
mobile phase. Fractions containing the product were combined and the solvent was removed to 
yield an off-white oil which was dried under vacuum over P2O5 overnight (1.490 g, 98.8% 
yield). Spectroscopic data matched that previously published.30  
Synthesis of m-(Aza-18-crown-6)methylphenol 
 A 200 mL Schlenk flask was charged with 348.6 mg (2.855 mmol) 3-
hydroxybenzaldehyde, 501.2 mg (1.903 mmol) 1-aza-18-crown-6, and 25 mL THF. The mixture 
was stirred for one hour and then 806.8 mg (3.807 mmol) sodium triacetoxyborohydride was 
added in 200 mg increments every ~6 hours over 24 hours. The reaction was stirred for an 
additional 24 hours and then quenched with aqueous saturated NaHCO3. The product was 
extracted into 4 x 20 mL of CH2Cl2 and the solvent of the combined extracts was removed. The 
crude product was purified using a short silica plug. Unreacted aldehyde and 3-
hydroxymethylphenol were eluted with a 60/40 (% v/v) CH2Cl2/EtOAc mobile phase until TLC 
showed no remaining traces of alcohol. The product was then eluted with an 85/10/5 
CH2Cl2/NEt3/MeOH (% v/v/v) mobile phase. Fractions containing the product were combined 
and the solvent was removed to yield an off-white oil which was dried under vacuum over P2O5 
overnight (689.1 mg, 98.0%). 1H NMR (600 MHz, CDCl3): d 2.71 (s, 4H, crown-CH2), 3.64 (m, 
22H, crown-CH2, ArCH2N), 6.66 (d, J = 7.6 Hz, 1H, ArH), 6.69 (d, J = 7.9 Hz, 1H, ArH), 7.09 (t, 
J = 7.8 Hz, 1H, ArH), 7.42 (s, 1H, ArH), 7.55 (s, 1H, ArOH). 13C {1H} NMR (151 MHz, CDCl3): 
d 55.75 (s, crown-CH2), 59.53 (s, ArCH2N), 70.05 (s, crown-CH2), 70.13 (s, crown-CH2), 70.56 
(s, crown-CH2), 70.75 (s, crown-CH2), 71.26 (s, crown-CH2), 113.55 (s, CAr), 115.73 (s, CAr), 
118.73 (s, CAr), 128.90 (s, CAr), 142.90 (s, CAr), 156.99 (s, CAr). Anal. Calcd for C19H31NO6: C, 
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61.77; H, 8.46; N, 3.79. Found: C, 61.51; H, 8.20; N, 3.80. HRMS (ESI+) m/z: [m-(Aza-18-
crown-6)methylphenol+H]+ Calcd for C19H32NO6 370.22241; Found 370.22231. 
 
Figure 3.29 1H NMR spectrum (600 MHz) of m-(aza-18-crown-6)methylphenol in CDCl3. 
 
Figure 3.30 13C {1H} NMR spectrum (151 MHz) of m-(aza-18-crown-6)methylphenol in CDCl3. 
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Synthesis of (18c6NCOPiPr)H 
 This compound was synthesized according to the literature procedure for the synthesis of 
(15c5NCOPiPr)H.30 In a 100 mL Schlenk flask, 278 µL (1.992 mmol) NEt3 was added dropwise to 
a stirring solution of 669.1 mg (1.811 mmol) m-(Aza-18-crown-6)methylphenol in 15 mL THF. 
The solution was stirred for 15 minutes and then a solution of 0.299 mL (1.808 mmol, 96%) 
chlorodiisopropyl phosphine in 10 mL THF was added dropwise. The resulting reaction mixture 
was stirred at 25 ºC for 12 hours. The solvent was then removed and the colorless oil was 
extracted with 4 x 10 mL Et2O. The solvent of the combined extracts was removed to yield a 
colorless oil (802.1 mg, 91% yield). 1H NMR (600 MHz, CDCl3): d 1.08 (dd, J = 15.9, 7.2 Hz, 
6H, CH(CH3)2), 1.16 (dd, J = 10.9, 7.3 Hz, 6H, CH(CH3)2), 1.90 (m, 2H, CH(CH3)2), 2.78 (t, J = 
5.9 Hz, 4H, crown-CH2), 3.65 (m, 22H, crown-CH2, ArCH2N), 6.93 (d, J = 7.5 Hz, 1H, ArH), 
6.95 (d, J = 7.9 Hz, 1H, ArH), 7.04 (s, 1H, ArH), 7.15 (t, J = 7.8 Hz, 1H, ArH). 13C {1H} NMR 
(151 MHz, CDCl3): d 17.17 (d, J = 8.6 Hz, CH(CH3)2), 17.91 (d, J = 20.0 Hz, CH(CH3)2), 28.40 
(d, J = 17.3 Hz, CH(CH3)2), 53.96 (s, crown-CH2), 60.07 (s, ArCH2N), 70.23 (s, crown-CH2), 
70.52 (s, crown-CH2), 70.93 (s, crown-CH2), 71.00 (s, crown-CH2), 117.03 (d, J = 11.0 Hz, CAr), 
119.00 (d, J = 9.4 Hz, CAr), 122.14 (s, CAr), 129.07 (s, CAr), 141.49 (s, CAr), 159.40 (d, J = 8.3 
Hz, CAr). 31P{1H} NMR (243 MHz, CDCl3): d 149.12 (s). Anal. Calcd for C25H44NO6P; C, 
61.84; H, 9.13; N, 2.88. Found: C, 61.80; H, 9.40; N, 2.88. HRMS (ESI+) m/z: 
[(18c6NCOPiPr)H+H]+ Calcd for C25H45NO6P 486.29790; Found 486.29782. 
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Figure 3.31 1H NMR spectrum (600 MHz) of (18c6NCOPiPr)H in CDCl3. 
 
Figure 3.32 31P{1H} NMR spectrum (243 MHz) of (18c6NCOPiPr)H in CDCl3. 
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Figure 3.33 13C {1H} NMR spectrum (151 MHz) of (18c6NCOPiPr)H in CDCl3. 
 
Synthesis of k3-(18c6NCOPiPr)NiBr (1-18c6) 
 A 100 mL Schlenk flask was charged with 281.0 mg (0.912 mmol) (DME)NiBr2 and 15 
mL toluene. In a separate flask, 442.9 mg (0.912 mmol) (18c6NCOPiPr)H was stirred with 381 µL 
(2.737 mmol) NEt3 in 15 mL toluene for 10 minutes, and the resulting mixture was then added 
dropwise to the stirring suspension of (DME)NiBr2. The flask was heated at 65 ºC for 12 h. After 
heating, the solution was filtered via cannula under N2, and the filtrate was evaporated to 
dryness. The resulting yellow oil was extracted with toluene and filtered. Diffusion of pentane 
into a saturated toluene solution at -30 ˚C yielded a first crop of yellow crystals that were washed 
with 3 × 5 mL of cold pentane (-30 ˚C) and dried under vacuum. The mother liquor was then 
removed in vacuo to give a yellow oil which was again recrystallized to give a second crop of 
yellow crystals that were washed with cold pentane and dried under vacuum (total 0.491 g, 
86.3% yield). 1H NMR (600 MHz, C6D6): d 1.20 (dd, J = 14.5, 7.0 Hz, 6H, CH(CH3)2), 1.52 (dd, 
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J = 17.3, 7.2 Hz, 6H, CH(CH3)2), 2.24 (m, 2H, CH(CH3)2), 3.25 (m, 8H, crown-CH2), 3.43 (m, 
4H, crown-CH2), 3.56 (m, 6H, crown-CH2), 3.67 (m, 2H, crown-CH2), 4.03 (m, 2H, crown-
CH2), 4.10 (m, 2H, crown-CH2), 4.61 (s, 2H, ArCH2N), 6.63 (d, J = 7.9 Hz, 1H, ArH), 6.66 (d, J 
= 7.4 Hz, 1H, ArH), 6.93 (t, J = 7.6 Hz, 1H ArH). 13C {1H} NMR (151 MHz, C6D6): d 16.98 (s, 
CH(CH3)2), 18.38 (d, J = 3.9 Hz, CH(CH3)2), 28.55 (d, J = 24.2 Hz, CH(CH3)2), 57.48 (d, J = 1.9 
Hz, crown-CH2), 65.88 (d, J = 1.7 Hz, ArCH2N), 69.58 (s, crown-CH2), 70.42 (s, crown-CH2), 
70.64 (s, crown-CH2), 70.97 (s, crown-CH2), 71.39 (s, crown-CH2), 107.83 (d, J = 13.1 Hz, CAr), 
115.96 (d, J = 2.0 Hz, CAr), 127.02 (s, CAr), 142.30 (d, J = 33.2 Hz, CAr), 154.49 (s, CAr), 165.85 
(d, J = 10.8 Hz, CAr). 31P{1H} NMR (243 MHz, C6D6): d 198.80 (s). Anal. Calcd for 
C25H43O6NPNiBr: C, 48.18; H, 6.96; N, 2.25. Found: C, 48.44; H, 6.70; N, 2.32. 
 
Figure 3.34 1H NMR spectrum (600 MHz) of k3-(18c6NCOPiPr)NiBr (1-18c6) in C6D6. 
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Figure 3.35 31P{1H} NMR spectrum (243 MHz) of k3-(18c6NCOPiPr)NiBr (1-18c6) in C6D6. 
 
Figure 3.36 13C {1H} NMR spectrum (151 MHz) of k3-(18c6NCOPiPr)NiBr (1-18c6) in C6D6. 
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Table 3.3 Crystal data and structure refinement for k3-(18c6NCOPiPr)NiBr (1-18c6). 
 
Identification code  x1602005  
Empirical formula  C25H43BrNNiO6P  
Formula weight  623.19  
Temperature/K  100.15  
Crystal system  monoclinic  
Space group  P21/c  
a/Å  21.6683(16)  
b/Å  14.7136(11)  
c/Å  17.7835(13)  
α/°  90  
β/°  91.302(4)  
γ/°  90  
Volume/Å3  5668.2(7)  
Z  8  
ρcalcg/cm3  1.461  
µ/mm-1  3.488  
F(000)  2608.0  
Crystal size/mm3  0.243 × 0.191 × 0.15  
Radiation  CuKα (λ = 1.54178)  
2Θ range for data collection/°  4.078 to 140.536  
Index ranges  -26 ≤ h ≤ 26, -17 ≤ k ≤ 17, -21 ≤ l ≤ 21  
Reflections collected  21494  
Independent reflections  10758 [Rint = 0.0437, Rsigma = 0.0477]  
Data/restraints/parameters  10758/0/639  
Goodness-of-fit on F2  1.078  
Final R indexes [I>=2σ (I)]  R1 = 0.0318, wR2 = 0.0762  
Final R indexes [all data]  R1 = 0.0373, wR2 = 0.0786  
Largest diff. peak/hole / e Å-3  0.65/-0.54  
 
 
Synthesis of [k4-(15c5NCOPiPr)Ni][PF6] (2-15c5) 
 In a glovebox, a solution of 41.2 mg (0.071 mmol) k3-(15c5NCOPiPr)NiBr (1-15c5) in 2 
mL CH2Cl2 was slowly added to a stirring solution of 18.8 mg (0.075 mmol) AgPF6 in 3 mL 
CH2Cl2 in a 20 mL vial covered with foil. After 1 hour, 4 mL of pentane was added to the 
mixture and the resulting solution was filtered. The solvent was removed in vacuo to yield a 
yellow oil. The oil was triturated with Et2O overnight and then the solution was decanted to yield 
a yellow powder (44.0 mg, 96.0% yield). 1H NMR (600 MHz, CDCl3): d 1.33 (dd, J = 14.4, 6.9 
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Hz, 6H, CH(CH3)2), 1.51 (dd, J = 19.0, 7.3 Hz, 6H, CH(CH3)2), 2.25 (m, 2H, CH(CH3)2), 3.19 
(m, 2H, crown-CH2), 3.56 (m, 2H, crown-CH2), 3.65 (m, 4H, crown-CH2), 3.75 (m, 6H, crown-
CH2), 3.95 (m, 4H, crown-CH2), 4.16 (s, 2H, ArCH2N), 4.29 (m, 2H, crown-CH2), 6.43 (d, J = 
8.3 Hz, 1H, ArH), 6.52 (d, J = 7.5 Hz, 1H, ArH), 6.97 (t, J = 7.8 Hz, 1H, ArH). 13C {1H} NMR 
(151 MHz, CDCl3): d 16.66 (d, J = 2.9 Hz, CH(CH3)2), 17.54 (d, J = 5.8 Hz, CH(CH3)2), 28.58 
(d, J = 24.1 Hz, CH(CH3)2), 54.61 (s, crown-CH2), 64.83 (s, ArCH2N), 68.64 (s, crown-CH2), 
69.31 (s, crown-CH2), 69.46 (s, crown-CH2), 75.02 (s, crown-CH2), 109.27 (d, J = 12.1 Hz, CAr), 
116.78 (s, CAr), 128.35 (s, CAr), 130.72 (d, J = 30.3 Hz, CAr), 152.61 (s, CAr), 165.82 (d, J = 8.2 
Hz, CAr). 31P{1H} NMR (162 MHz, CDCl3): d 197.42 (s), –143.06 (hept, J = 712.8 Hz, PF6). 
Anal. Calcd for C23H39F6NNiO5P2: C, 42.88; H, 6.10; N, 2.17. Found: C, 42.78; H, 5.92; N, 2.17. 
 
Figure 3.37 1H NMR spectrum (600 MHz) of [˚k4-(15c5NCOPiPr)Ni][PF6] (2-15c5) in CDCl3. 
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Figure 3.38 31P{1H} NMR spectrum (162 MHz) of [k4-(15c5NCOPiPr)Ni][PF6] (2-15c5) in 
CDCl3. 
 




Table 3.4 Crystal data and structure refinement for [k4-(15c5NCOPiPr)Ni][PF6] (2-15c5). 
 
Identification code  p21c_a  
Empirical formula  C23H39F6NNiO5P2  
Formula weight  644.20  
Temperature/K  100.15  
Crystal system  monoclinic  
Space group  P21/c  
a/Å  9.9688(2)  
b/Å  25.1718(4)  
c/Å  12.0203(2)  
α/°  90  
β/°  108.8070(9)  
γ/°  90  
Volume/Å3  2855.25(9)  
Z  4  
ρcalcg/cm3  1.499  
µ/mm-1  2.703  
F(000)  1344.0  
Crystal size/mm3  0.279 × 0.161 × 0.115  
Radiation  CuKα (λ = 1.54178)  
2Θ range for data collection/°  7.024 to 130.09  
Index ranges  -11 ≤ h ≤ 11, -28 ≤ k ≤ 29, -13 ≤ l ≤ 11  
Reflections collected  29104  
Independent reflections  4759 [Rint = 0.0313, Rsigma = 0.0211]  
Data/restraints/parameters  4759/0/347  
Goodness-of-fit on F2  1.033  
Final R indexes [I>=2σ (I)]  R1 = 0.0286, wR2 = 0.0706  
Final R indexes [all data]  R1 = 0.0338, wR2 = 0.0732  
Largest diff. peak/hole / e Å-3  0.34/-0.33  
 
Synthesis of [k4-(18c6NCOPiPr)Ni][PF6] (2-18c6) 
 The procedure described above for the preparation of [k4-(15c5NCOPiPr)Ni][PF6] (5-15c5) 
was used to prepare [k4-(18c6NCOPiPr)Ni][PF6] from k3-(18c6NCOPiPr)Ni(Br) (1-18c6) and AgPF6 
to yield a yellow powder. 1H NMR (600 MHz, CD2Cl2): d 1.35 (dd, J = 14.4, 6.9 Hz, 6H, 
CH(CH3)2), 1.44 (dd, J = 19.0, 7.3 Hz, 6H, CH(CH3)2), 2.22 (m, 2H, CH(CH3)2), 3.24 (m, 2H, 
crown-CH2), 3.64 (m, 18H, crown-CH2), 4.02 (m, 2H, crown-CH2), 4.18 (m, 4H, crown-CH2; 
ArCH2N), 6.47 (d, J = 8.0 Hz, 1H, ArH), 6.58 (d, J = 7.5 Hz, 1H, ArH), 7.00 (t, J = 7.8 Hz, 1H, 
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ArH). 13C {1H} NMR (151 MHz,CD2Cl2): d 16.80 (s, CH(CH3)2), 17.71 (d, J = 5.9 Hz, 
CH(CH3)2), 28.70 (d, J = 24.1 Hz, CH(CH3)2), 64.63 (s, ArCH2N), 69.92 (s, crown-CH2), 70.57 
(s, crown-CH2), 70.86 (s, crown-CH2), 74.18 (s, crown-CH2), 109.61 (d, J = 12.1 Hz, CAr), 
117.49 (s, CAr), 128.75 (s, CAr), 131.35 (s, CAr), 152.98 (s, CAr), 166.15 (d, J = 8.3 Hz, CAr). 
31P{1H} NMR (243 MHz, CD2Cl2): d 196.28 (s), –144.30 (hept, J = 711.5 Hz, PF6) HRMS 
(ESI+) m/z: [k4-(18c6NCOPiPr)Ni]+ Calcd for C25H43NNiO6P 542.21815; Found 542.21678. 
 



















































Figure 3.41 31P{1H} NMR spectrum (243 MHz) of [k4-(18c6NCOPiPr)Ni][PF6] (2-18c6) in 
CD2Cl2. 
 


















































Synthesis of [k4-(15c5NCOPiPr)Ni][BArF4] (3-15c5) 
 A solution of 32.6 mg (0.0506 mmol) [k4-(15c5NCOPiPr)Ni][PF6] (2-15c5) in 1 mL 
CH2Cl2 was added to a stirring suspension of 47.0 mg (0.0530 mmol) NaBArF4 in 2 mL CH2Cl2. 
The suspension was stirred for 1 hour after which 3 mL pentane was added, and the resulting 
solution was filtered. The solvent was removed to yield a yellow oil. The oil was triturated with 
Et2O and then the solution was decanted to yield a tacky solid which when dried under vacuum 
gave a yellow powder (0.0662 g, 96.0% yield). 1H NMR (500 MHz, CD2Cl2): d 1.32 (dd, J = 
14.5, 7.0 Hz, 6H, CH(CH3)2), 1.47 (dd, J = 18.9, 7.3 Hz, 6H, CH(CH3)2), 2.20 (m, 2H, 
CH(CH3)2), 3.22 (m, 2H, crown-CH2), 3.64 (m, 14H, crown-CH2), 3.91 (m, 2H, crown-CH2), 
4.15 (s, 2H, ArCH2N), 4.42 (m, 2H, crown-CH2), 6.48 (d, J = 8.0 Hz, 1H, ArH), 6.56 (d, J = 7.6 
Hz, 1H, ArH), 7.01 (t, J = 7.8 Hz, 1H, ArH), 7.56 (s, 4H, p-B-Ar-H), 7.72 (s, 8H, m-B-Ar-H). 13C 
{1H} NMR (151 MHz, CD2Cl2): d 16.78 (d, J = 2.5 Hz, CH(CH3)2), 17.76 (d, J = 5.8 Hz, 
CH(CH3)2), 29.00 (d, J = 24.2 Hz, CH(CH3)2), 54.63 (s, crown-CH2), 64.66 (s, ArCH2N), 68.88 
(s, crown-CH2), 69.60 (s, crown-CH2), 69.89 (s, crown-CH2), 75.39 (s, crown-CH2), 109.94 (d, J 
= 12.2 Hz, CAr), 117.51 (d, J = 2.1 Hz, CAr), 117.85 (m, para-CH, BArF4), 124.95 (q, J = 272.3 
Hz, CF3, BArF4), 129.03 (s, CAr), 129.21 (qdd, J = 32.1, 5.8, 2.8, C–CF3, BArF4), 130.74 (d, J = 
29.9 Hz, CAr), 135.15 (s, ortho-CH, BArF4), 152.59 (s, CAr), 162.10 (q, J = 50.0 Hz, B–C, 
BArF4), 166.16 (d, J = 8.2 Hz, CAr). 31P{1H} NMR (202 MHz, CD2Cl2): d 195.42 (s). HRMS 
(ESI+) m/z: [k4-(15c5NCOPiPr)Ni]+ Calcd for C23H39NNiO5P 498.19193; Found 498.19075. 
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Figure 3.43 1H NMR spectrum (500 MHz) of [k4-(15c5NCOPiPr)Ni][BArF4] (3-15c5) in CD2Cl2. 
 




































































Figure 3.45 13C {1H} NMR spectrum (151 MHz) of [k4-(15c5NCOPiPr)Ni][BArF4] (3-15c5) in 
CD2Cl2. 
 
General Procedure for Titrations in CD2Cl2 
 A 10 mM stock solution of the corresponding Ni complex was prepared in CH2Cl2, and 
250 µL aliquots (2.5 × 10−3 mmol) of the solution were added to seven glass vials. The protio 
solvent was completely evaporated. A 10 mM stock solution of LiBArF4·3Et2O or NaBArF4 was 
prepared in CD2Cl2. For LiBArF 4·3Et2O solutions, 12 equiv of Et2O were added for a total of 
15 equiv, and for NaBArF4 solutions, 15 equiv of Et2O were added. Aliquots of the alkali metal 
stock solution corresponding to 0.25−2.0 equiv (between 6.3 × 10−4 and 5.0 × 10−3 mmol) of 
alkali metal to transition metal complex were then added to the vials containing the Ni 
complexes. The samples were diluted to a total volume of 500 µL with CD2Cl2, transferred to 
NMR tubes, and analyzed at 20 ± 1 °C by 1H NMR spectroscopy. The final concentration of the 
Ni complex in solution was 5 mM. The final concentration of alkali metal in the samples ranged 























































General Procedure for CD3CN Titrations 
 A 12 mM stock solution of the corresponding Ni complex and a 48 mM stock solution of 
the corresponding alkali metal salt were prepared in CH3CN. 500 µL aliquots (6.0 × 10−3 mM) of 
the Ni stock solution were added to eight glass vials. Aliquots of the alkali metal stock solution 
corresponding to 0.5−10 equiv (between 3.0 × 10−3 and 60 × 10−3 mM) of alkali metal salt to Ni 
complex were then added to the vials containing the Ni complex. The protio solvent was 
completely evaporated. The samples were then dissolved in 600 µL of CD3CN, transferred to 
NMR tubes, and analyzed by 1H NMR spectroscopy at 24 ± 1 °C. The final concentration of Ni 
in solution was 10 mM. The final concentration of alkali metal in the samples ranged from 0 to 
120 mM. On the basis of triplicate titrations of 1-15c5 with LiOTf and 1- 18c6 with NaBArF4, 
the estimated uncertainty of each equilibrium constant is 10% or less. 
Table 3.5 Crystal data and structure refinement for [(Li+@k3-15c5NCOPiPr)Ni(Br)][PF6] (Li+•1-
15c5). 
 
Identification code  sad  
Empirical formula  C23H39BrF6LiNNiO5P2  
Formula weight  731.05  
Temperature/K  100.15  
Crystal system  monoclinic  
Space group  C2/c  
a/Å  31.1444(5)  
b/Å  14.6199(2)  
c/Å  16.2913(3)  
α/°  90  
β/°  118.0863(10)  
γ/°  90  
Volume/Å3  6544.35(19)  
Z  8  
ρcalcg/cm3  1.484  
µ/mm-1  3.802  
F(000)  2992.0  
Crystal size/mm3  0.097 × 0.051 × 0.047  
Radiation  CuKα (λ = 1.54178)  
2Θ range for data collection/°  6.434 to 144.398  
Index ranges  -29 ≤ h ≤ 38, -16 ≤ k ≤ 17, -20 ≤ l ≤ 11  
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Reflections collected  20172  
Independent reflections  6280 [Rint = 0.0429, Rsigma = 0.0371]  
Data/restraints/parameters  6280/0/365  
Goodness-of-fit on F2  1.031  
Final R indexes [I>=2σ (I)]  R1 = 0.0337, wR2 = 0.0842  
Final R indexes [all data]  R1 = 0.0409, wR2 = 0.0882  
Largest diff. peak/hole / e Å-3  0.58/-0.47  
 
Table 3.6. Crystal data and structure refinement for [(Li+@k3-15c5NCOPiPr)Ni(Br)][OTf] 
(LiOTf•1-15c5). 
 
Identification code  JBS32_0m  
Empirical formula  C24H39BrF3LiNNiO8PS  
Formula weight  735.15  
Temperature/K  100  
Crystal system  monoclinic  
Space group  C2/c  
a/Å  32.0868(4)  
b/Å  14.5760(2)  
c/Å  16.2503(3)  
α/°  90  
β/°  118.2514(9)  
γ/°  90  
Volume/Å3  6694.87(18)  
Z  8  
ρcalcg/cm3  1.459  
µ/mm-1  3.788  
F(000)  3024.0  
Crystal size/mm3  0.25 × 0.25 × 0.05  
Radiation  CuKα (λ = 1.54178)  
2Θ range for data collection/°  6.254 to 140.076  
Index ranges  -39 ≤ h ≤ 34, -17 ≤ k ≤ 17, -13 ≤ l ≤ 19  
Reflections collected  42652  
Independent reflections  6153 [Rint = 0.0603, Rsigma = 0.0347]  
Data/restraints/parameters  6153/0/374  
Goodness-of-fit on F2  1.041  
Final R indexes [I>=2σ (I)]  R1 = 0.0419, wR2 = 0.0879  
Final R indexes [all data]  R1 = 0.0560, wR2 = 0.0956  




Table 3.7. Crystal data and structure refinement for [(Na+@k3-15c5NCOPiPr)Ni(Br)][BArF4] 
(Na+•1-15c5). 
 
Identification code  x1506005  
Empirical formula  C59H61BBrF24NNaNiO6P  
Formula weight  1539.47  
Temperature/K  100  
Crystal system  triclinic  
Space group  P-1  
a/Å  12.6561(9)  
b/Å  16.4078(11)  
c/Å  16.9035(12)  
α/°  90.927(4)  
β/°  109.622(3)  
γ/°  93.354(3)  
Volume/Å3  3298.2(4)  
Z  2  
ρcalcg/cm3  1.550  
µ/mm-1  2.481  
F(000)  1560.0  
Crystal size/mm3  0.326 × 0.176 × 0.128  
Radiation  CuKα (λ = 1.54178)  
2Θ range for data collection/°  5.4 to 133.652  
Index ranges  -11 ≤ h ≤ 14, -19 ≤ k ≤ 19, -20 ≤ l ≤ 20  
Reflections collected  37607  
Independent reflections  11324 [Rint = 0.0481, Rsigma = 0.0407]  
Data/restraints/parameters  11324/60/901  
Goodness-of-fit on F2  1.074  
Final R indexes [I>=2σ (I)]  R1 = 0.0382, wR2 = 0.0898  
Final R indexes [all data]  R1 = 0.0491, wR2 = 0.0974  
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CHAPTER 4: ORGANOMETALLIC ELABORATION OF AZA-CROWN ETHERS: 
POST-MACROCYLIZATION CONTROL OF BINDING AFFINITY AND 




 Crown ethers are the quintessential example of supramolecular hosts capable of strong 
ion binding and selective ion recognition. The early chemistry of crown ethers helped spark 
development1 of host-guest complexes with synthetically tunable molecular recognition and has 
led to acclaimed impact on applications2 in a variety of fields including sensing,3 separations,4-5 
and molecular machines.6  
Hundreds of macrocyclic structures have been prepared using synthetic organic methods 
in the search for crown ethers with desirable ion recognition properties.7-8 New crown ethers are 
typically prepared via macrocyclization reactions that can be tedious, unselective, and low-
yielding.9-10 Post-macrocyclization synthetic modification, such as in the installation of side 
chains in “lariat” ethers, offers another attractive strategy.11-12 A less studied, but no less 
intriguing, strategy involves allosteric modulation of host-guest properties in analogy to 
enzymatic cofactor-triggered structural and chemical changes.13 Transition metal coordination 
chemistry has enabled allosteric regulation of the host-guest properties of supramolecular 
constructs.14-16 A bipyridine unit incorporated into the macrocycle often serves to bind a 
transition metal, thereby altering the binding properties of crown ethers,17-19 calix[4]arenes20 and 
polycationic cylcophanes.21 
Organometallic moieties have rarely been employed to tune the cation-binding properties 
of macrocycles,22 despite promising several advantages over inorganic coordination complexes. 
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Firstly, the strong metal–ligand interactions of organometallic complexes would prevent 
competing binding by the guest molecules. In addition, mature organometallic synthetic 
transformations could allow elaboration of the organometallic unit for further tuning. The 
inclusion of a tightly bound metal center proximal to a cation-selective macrocycle could also 
serve to enable ion pair recognition. Examples of the latter phenomenon were recently reported, 
with the installation of alkyltin groups converting simple crown ethers from cation receptors to 
ion pair receptors.23-25 New strategies for rapid organometallic elaboration of crown ethers could 
provide robust, flexible platforms for allosteric modulation of host-guest properties. 
Our group recently developed pincer-crown ether ligands that incorporate an aza-crown 
ether macrocycle into a phenylphosphinite “pincer-crown ether” framework.26 For applications 
in organometallic catalysis, the macrocycle acts as an allosteric receptor whereby cation binding 
tunes the hemilability of the metal-oxygen bonds and modulates substrate access to the transition 
metal center.27-31 In the course of a detailed thermodynamic study of cation-crown binding 
affinity relevant of nickel pincer-crown ether complexes (Chapter 3),32 it became clear that 
organometallic macrocycles have quite different properties from simple organic crown ethers. 
Thus, the phenylphosphinite site might act as an allosteric receptor whereby the properties of the 
transition metal center can tune the cation binding properties of the crown ether. The pincer-
crown ether framework, accessible from 1-aza-15-crown-5 in just two synthetic steps, provides a 
convenient platform to understand how organometallic elaborations of a simple crown ether can 




Figure 4.1 Depiction of an iridium pincer-crown ether complex highlighting the macrocyclic 
cation receptor and the coordination site that offers tunability through organometallic 
elaboration. 
 
This report demonstrates that facile synthetic elaboration of 1-aza-15-crown-5 to form 
organometallic pincer-crown ether complexes results in dramatic changes in binding affinity and 
cation selectivity, including strikingly high selectivity for Li+ over Na+. The binding affinity can 
be fine-tuned based on the choice of transition metal ion in the organometallic site, or by 
adjusting the supporting ligands or oxidation state of the transition metal after installation. A 
change in topicity is also observed, with the cation-binding 1-aza-15-crown-5 converted into a 
heteroditopic ion pair receptor. 
4.2 Impact of Ir Metalation on Binding Affinity and Selectivity 
 
 To illustrate the ability of organometallic chemistry to alter the cation binding properties 
of a simple aza-crown ether, the Li+ and Na+ binding affinities were measured in CD3CN for 
each species along the synthetic pathway of Scheme 4.1 (see Experimental Section for 
titration/isotherm data). Starting from the well-characterized macrocycle 1-aza-15-crown-5 
ether,33 reductive amination provides m-(Aza-15-crown-5)methylphenol (1).31-32 The pincer-
crown ether ligand precursor 1 binds Li+ and Na+ cations tightly and in a 1:1 fashion in CD3CN 


















1H NMR spectroscopic titrations until 1 added equiv of cation relative to the macrocycle. A 
competitive binding technique provided association constants (Ka) with both LiOTf (Ka = 
126,000 M–1) and NaBArF4 (Ka = 79,400 M–1).34 These values are similar to affinities of 
substituted N-benzylaza-15-crown-5 ethers under similar conditions.35 Both systems show only 
modest selectivity between Li+ and Na+; the prior work had KLi/KNa ~ 0.09, while 1 has KLi/KNa ~ 
2. Phosphination of 1 provides the known pincer-crown ether ligand (15c5NCOPiPr)H (2),29, 32 
which maintains strong interactions with Li+ and Na+ in CD3CN at 25  ± 1 °C. Binding affinities 




Scheme 4.1 Synthetic pathway and association constants for lithium and sodium binding to 
(pre)ligands and iridium pincer-crown ether complexes. (i) 3-hydroxybenzaldehyde, sodium 
triacetoxyborohydride, THF. (ii) iPr2PCl, NEt3, THF. (iii) Ir(p-toluidine)(CO)2(Cl), toluene. (iv) 
KOtBu, toluene. See Experimental Section for full synthetic details. 
 
The phenylphosphinite motif of 2 provides a binding pocket for transition metal ions. 
Metallation with Ir(p-toluidine)(CO)2(Cl) provides the d6 Ir(III) complex (k3-
15c5NCOPiPr)Ir(H)(CO)(Cl) (3).36-37 Titration of 3 with LiOTf and NaBArF4 revealed association 
constants of Ka = 560 M-1 and Ka = 19 M-1 respectively. Metallation of the ligand with Ir leads to 
a 3-4 order of magnitude decrease in Li+ and Na+ binding strength. Dehydrohalogenation of 
complex 3 with KOtBu provides another neutral iridium species, (k3-15c5NCOPiPr)Ir(CO) (4).37 
The formal oxidation state of iridium changes from +3 to +1 during this synthetic step, and the 



































(i) (ii) (iii) (iv)
Ka(Li+) = 158,500 M–1
Ka(Na+) = 39,800 M–1
KLi/Na = 4.0
Ka(Li+) = 126,000 M–1
Ka(Na+) = 79,400 M–1
KLi/Na = 1.6
Ka(Li+) = 126,000 M–1
Ka(Na+) = 79,400 M–1
KLi/Na = 1.6
Ka(Li+) = 563 M–1
Ka(Na+) = 19 M–1
KLi/Na = 30
Ka(Li+) = 184 M–1
Ka(Na+) = 26 M–1
KLi/Na = 7
1-aza-15-crown-5 1 2 3 4
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metal center lead to a three-fold change in Li+ binding affinity, based on NMR titrations of 4 
with LiOTf and NaBArF4 that provide Ka(Li+) = 184 M-1 and Ka(Na+) = 26 M-1. 
A straightforward series of synthetic steps increases Li+ selectivity almost 30-fold while 
significantly reducing the binding affinity for each cation. It is striking that alkylation and 
phosphination of 1-aza-15-crown-5 ether hardly perturb the host-guest properties at all, while 
metalation and a subsequent organometallic step significantly modulate the binding affinity and 
cation selectivity. We attribute the reduction in binding affinity to the amine donation to the 
transition metal center, which reduces the crown ether donor number and opens a pathway for 
inductive electron withdrawing effects (a resonance structure with a positive charge on N can be 
drawn). In CH3CN, the larger 1-aza-15-crown-5 ether binds Li+ and Na+ with KLi = 158,500 M–1 
and KNa = 39,800 M–1 while the smaller, N-donor lacking 12-crown-4 ether binds Li+ and Na+ 
with KLi = 2,500 M–1 and KNa = 2000 M–1.38-39 The origin of the change in cation selectivity is 
less clear, although it is noteworthy that some of the crown ethers with the highest Li+ selectivity 
over Na+ feature long linker lengths between some of the oxygen atoms.40 These observations 
led us to undertake a more systematic study of the ability of organometallic synthetic alterations 
to tune the host-guest properties of the crown ether. 
4.3 Central Transition Metal Influence on Affinity and Selectivity 
 
 Noting the large differences in binding affinity and cation selectivity upon metalation to 
form an organometallic macrocycle, we set out to explore the influence of the transition metal on 
host-guest properties. An isoelectronic series with d8 square planar organometallic fragments was 
targeted starting from (k3-15c5NCOPiPr)Ni(Cl) (5-Cl). The nickel chloride complex 5-Cl was 
accessed by heating a toluene solution of ligand 2 with NiCl2(DME) (DME is 1,2-
dimethoxyethane), in analogy to the procedure for the bromide complex.28, 32 The Pd complex 
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(k3-15c5NCOPiPr)Pd(Cl) (6) was prepared by refluxing ligand 2 with PdCl2(COD) (COD is 1,4-
cyclooctadiene) in toluene for 2 h. The Pt complex (k3-15c5NCOPiPr)Pt(Cl) (7) was synthesized 
by refluxing ligand 2 and PtCl2(SMe2)2 in toluene for 5 h. Multinuclear NMR spectroscopy and 
single-crystal X-ray diffraction (XRD) analysis confirm a tridentate binding mode for 5-Cl, 6, 
and 7 that leaves all four ether oxygen atoms free for binding cations (see Experimental Section 




Figure 4.2 Metalation of (15c5NCOPiPr)H (2) with Ni, Pd, or Pt and the corresponding Ka(Li+) for 


















M = Ni, Ka(Li+) = 92 M–1, 5-Cl
M = Pd, Ka(Li+) = 277 M–1, 6
M = Pt, Ka(Li+) = 184 M–1, 7
Metalation
Ni, Pd, or Pt
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Figure 4.3 Structural representation of 6 with ellipsoids drawn at the 50% probability level. 
Hydrogen atoms omitted for clarity. Selected distances (Å) and angles (deg): Pd–P 2.1871(5), 
Pd–N 2.185(2), Pd–Cl 2.3788(5), Pd–C1 1.959(2), P–Pd–Cl 99.80(2), P–Pd–C1 80.83(6), N–Pd–
Cl 97.96(4), N–Pd–C1 81.16(7). 
 
 
Figure 4.4 Structural representation of 7 with ellipsoids drawn at the 50% probability level. 
Hydrogen atoms omitted for clarity. Selected distances (Å) and angles (deg): Pt–P 2.1717(9), Pt–
N 2.183(2), Pt–Cl 2.3825(9), Pt–C1 1.954(3), P–Pt–Cl 101.05(3), P–Pt–C1 81.92(9), N–Pt–Cl 
95.94(7), N–Pt–C1 80.9(1). 
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The binding affinity of each group 10 organometallic complex with LiOTf was 
established by 1H NMR titration. The nickel complex 5-Cl (Ka = 92 M–1) binds Li+ weakest, 
while Pd complex 6 (Ka = 277 M-1) and Pt complex 7 (Ka = 184 M-1) bind the Li+ salt 
approximately 3-fold and 2-fold tighter, respectively. Plotting the natural log of the binding 
affinity of the group 10 complexes and the isoelectronic Ir(I) complex 4 versus Allred-Rochow 
electronegativity (A-R EN) reveals a good linear correlation (Figure 4.3). 
 
Figure 4.5 Correlation of the natural log of Ka(Li+) of 5-Cl, 6, and 7 with Allred-Rochow 
Electronegativity. 
 
The correlation with electronegativity suggests that the electronic structure of the metal 
can significantly influence the binding affinity inductively through the bound amine of the aza-
crown ether. The metals with higher electronegativity parameters will withdraw more electron 
density from the amine and in turn withdraw more electron density from the ether oxygen atoms, 















7 Pt 4 Ir
5-Cl Ni
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4.4 Further Organometallic Elaboration 
 
 The various organometallic crown ethers could be further elaborated using routine 
inorganic synthetic techniques that modify the transition metal ion primary coordination sphere. 
Halide ligand substitution was selected as an example of a synthetically facile interconversion 
with minimal structural change. The binding affinity of a series of three pincer-crown ether 
nickel halide complexes with LiOTf was examined. The chloride complex 5-Cl (Ka = 92 M–1) 
was introduced above, while the bromide analogue, 5-Br (Ka = 91 M–1), was previously 
characterized as a model system for cation-tunable catalysis. These two macrocyclic complexes 
have similar Li+ binding affinities. The iodide complex (k3-15c5NCOPiPr)Ni(I) (5-I) was prepared 
by addition of excess NaI to a stirring acetone solution of 5-Br.41 The iodide complex binds 
LiOTf slightly stronger than the other halide complexes, Ka = 117 M-1. The halide lone pairs may 
act as additional donors to the cationic guests, as evidenced by a solid state structure of (k3-
15c5NCOPiPr)Ni(Br){NaBArF} in which the bromide bridges the nickel and sodium ions.32 A 
strong bridging interaction of this type might explain the increased affinity of 5-I for LiOTf. 
To further investigate the influence of the nickel coordination sphere on cation-crown 
interactions, the halide was replaced by a neutral acetonitrile donor ligand to form the cationic 
complex [(k3-15c5NCOPiPr)Ni(NCCD3)][BArF4] (8).28, 32 Titration of 8 with LiBArF4•3 Et2O gave 
Ka ≤ 10 M-1, an order-of-magnitude decrease in binding affinity achieved by a simple halide 
abstraction. This decrease in binding affinity is attributed to unfavorable electrostatic interactions 




Figure 4.6 Effects of ligand substitution and charge on the Ka(Li+) of nickel and iridium pincer-
crown ether complexes. 
 
The iridium hydridocarbonyl chloride complex 3 also undergoes facile halide abstraction 
to produce the cationic nitrile complex [(k3-15c5NCOPiPr)Ir(H)(CO)(NCCH3)][BArF4] (9).37 
Titration of 9 with LiBArF4 • 3 Et2O gave Ka = 45 M-1. This result suggests that the strategy of 
changing the charge on the transition metal center is a general method for tuning binding affinity, 
with a roughly 10-fold change in affinity for both Ni and Ir cases. Simple post-macrocyclization 
ligand substitution reactions can significantly alter the cation binding affinity of the pincer-crown 
ethers. 
4.5 Ditopic Binding 
 
Incorporating a transition metal center into a crown ether provides a proximal site for 
anion binding. The proclivity of the late transition metal ions for halides is clear from the 
abundance of halide complexes described above. Thus, beyond providing a handle for tuning 
cation affinity and selectivity, the elaboration with pincer complexes provides an opportunity to 
turn a simple cation-binding aza-crown ether into a ditopic receptor that binds both cations and 
anions. Heteroditopic receptors have emerged as promising structures for binding specific pairs 
of ions. Ion-pair receptors can provide energetic advantages through cooperative effects, and 



















L = Cl/Br/I, n = 0, 5-Cl/5-Br/5-I
Ka(Li+) for L = Cl  92 M–1;  L = Br 91 M–1; L = I 112 M–1
L = NCCD3, n = 1, Ka(Li+) = 12 M–1, 8
L = Cl, n = 0, Ka(Li+) = 563 M–1, 3
L = NCCD3, n = 1, Ka(Li+) 45 M–1, 9
n+
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transport, salt extraction, salt solubilization, and sensors.42-45 Few organotransition metal ditopic 
receptors exist.42  
The complex (k4-15c5NCOPiPr)Ir(H)(Cl) (10) has been shown to engage in equilibrium 
binding of additional halide equivalents (Bu4N+ X–) to form anionic complexes of the type [(k3-
15c5NCOPiPr)Ir(H)(X)2][A].29, 46 In CD2Cl2, complex 10 does not bind cations in the absence of a 
donor ligand to displace the crown ether. Addition of solid LiCl to 10 in CD2Cl2 resulted in ~ 35 
% conversion to [(k3-15c5NCOPiPr)Ir(H)(Cl)2][Li] (11) after 12 h at room temperature. This is 
evidenced by appearance of new resonances in the crown region and a new hydride resonance 
downfield of that of 10 (d –23.8 vs. –31.4) in 1H NMR spectra as well as a new 31P resonance 
downfield of that corresponding to 10 (d 142.8 vs 142.1). The large hydride shift is indicative of 
crown displacement to position a halide ligand trans to the hydride. Additionally, 7Li NMR 
spectra show a well resolved resonance indicating that LiCl has been pulled into solution. Under 
the same conditions, LiCl alone is undetectable by 7Li NMR spectroscopy and addition of an 
excess of the partially soluble chloride salt tetramethylammonium chloride ([Me4N][Cl]) to 10 
results in only 12 % conversion to [(k3-15c5NCOPiPr)Ir(H)(Cl)2][Me4N]. These preliminary results 
































 Fitting an aza-crown ether with a phenylphosphinite ligand provides an entry for 
organometallic tuning of the host-guest properties. Three dramatic changes are observed upon 
moving from the simple organic macrocycle to an organometallic pincer-crown ether. (1) The 
binding affinity for Li+ and Na+ salts is reduced substantially; the amine donates to the transition 
metal center, reducing the crown ether donor number and providing a pathway for inductive 
electronic withdrawing effects. (2) The selectivity for Li+ over Na+ increases dramatically, by as 
much as 30-fold; the long linking unit between ethers that contains the transition metal center 
may provide better conformations for the smaller cation. (3) The ion binding properties shift 
fundamentally to enable heteroditopic binding of ion pairs; the transition metal center provides 
an anion binding site in close proximity to the cation-binding crown ether, with direct cation–
anion bridges possible. 
Each of these properties can be further tuned through organometallic synthesis. The 
choice of transition metal ion has a significant impact on the binding affinity, for example. 
Ligand substitution on a particular transition metal complex leads to substantial shifts in the 
crown ether Li+ binding affinity. The electronic structure of the transition metal can favor or 
disfavor ditopic binding, as well, with neutral square planar transition metal complexes expected 
to have low halide affinity relative to cationic transition metal complexes with d6 configurations. 
No competition for the binding sites is observed in this system, thanks to the strong 
phenylphosphinite donor set. 
This new strategy for post-macrocyclization modification takes advantage of the 
synthetic versatility and structural diversity of organometallic complexes to give both 
transformational changes and fine-tuned adjustments in the host-guest properties of crown ethers.  
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4.7 Experimental Section 
 
General Considerations 
Standard vacuum line and glovebox techniques were utilized to maintain a N2 atmosphere 
during manipulation of all compounds, unless otherwise noted. Organic solvents were dried and 
degassed with argon using a Pure Process Technology solvent system and stored over 3 Å 
molecular sieves. Under standard glovebox operating conditions, pentane, diethyl ether, benzene, 
toluene, and tetrahydrofuran were used without purging, so traces of those solvents were present 
in the atmosphere and in the solvent bottles. 1H, 31P, and 13C NMR spectra were recorded on 400, 
500, 600, or 850 MHz spectrometers. NMR characterization data are reported at 25 °C, unless 
specified otherwise. All NMR solvents were purchased from Cambridge Isotopes Laboratories. 
Acetonitrile-d3 (CD3CN), benzene-d6 (C6D6), and methylene chloride-d2 (CD2Cl2) were 
freeze−pump−thaw-degassed three times, dried by passage through a small column of activated 
alumina, and stored over 3 Å molecular sieves. 1H and 13C chemical shifts are reported in parts 
per million relative to residual protio solvent resonances. All 31P resonances are reported relative 
to 85% H3PO4 external standard (δ 0). The following compounds were synthesized according to 
literature procedures: (15c5NCOPiPr)H,31-32 NaBArF4,47 LiBArF4,29 Pd(COD)Cl2,48 Pt(SMe2)2Cl2,49 
(κ3-15c5NCOPiPr)Ni(Br),32 [(κ4-15c5NCOPiPr)Ni][BArF4],32 (κ3-15c5NCOPiPr)Ir(CO),37 and (κ3-
15c5NCOPiPr)Ir(H)(CO)(Cl),37 [(κ3-15c5NCOPiPr)Ir(H)(CO)(NCCH3)][BArF4].37 LiOTf was dried 
under reduced pressure at 100 ˚C for 24 h prior to storage in a N2 glovebox. All other reagents 
were commercially available and used without further purification. Elemental analyses were 
performed by Robertson Microlit Laboratories (Ledgewood, NJ). 
Single-crystal X-ray diffraction data were collected on a Bruker Smart Apex-II 
diffractometer at 100 ± 2 K with Cu Kα radiation (λ = 1.54175 Å). Diffraction profiles were 
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integrated using the SAINT software program. Absorption corrections were applied using 
SADABS. The structure was solved using direct methods and refined using the XL refinement 
package via the least-squares method. Hydrogen atoms were generated theoretically and refined 
isotropically with fixed thermal factors. 
Synthetic Procedures 
Synthesis of (15c5NCOPiPr)Ni(Cl)  
The procedure described for the preparation of (15c5NCOPiPr)Ni(Br) was used to prepare 
(15c5NCOPiPr)Ni(Cl) from 145.4 mg (0.662 mmol) NiCl2(DME), 291.8 mg (0.661 mmol) 
(15c5NCOPiPr)H, and 0.230 mL (1.65 mmol) NEt3. The crude product was isolated as a red-
yellow oil and was recrystallized from a saturated toluene solution layered with pentane at -30 ˚C 
to yield yellow crystals that were washed with pentane and dried in-vacuo (170.3 mg, 44.5% 
yield). 1H NMR (600 MHz, C6D6): δ 1.17 (dd, J = 14.4, 7.0 Hz, 6H, CH(CH3)2), 1.47 (dd, J = 
17.4, 7.2 Hz, 6H, CH(CH3)2), 2.13 (m, 2H, CH(CH3)2), 3.29 (m, 12H, crown-CH2), 3.55 (m, 2H, 
crown-CH2), 3.69 (m, 2H, crown-CH2), 4.06 (m, 2H, crown-CH2), 4.17 (m, 2H, crown-CH2), 
4.42 (s, 2H, ArCH2N), 6.50 (d, J = 7.4 Hz, 1H, ArH), 6.59 (d, J = 7.9 Hz, 1H, ArH), 6.88 (t, J = 
7.7 Hz, 1H, ArH). 13C{1H} NMR (151 MHz, C6D6): δ 16.89 (s, CH(CH3)2), 17.95 (d, J = 4.6 Hz, 
CH(CH3)2), 28.07 (d, J = 23.5 CH(CH3)2), 57.00 (s, crown-CH2), 66.04 (s, ArCH2N), 69.75 (s, 
crown-CH2), 70.66 (s, crown-CH2), 70.95 (s, crown-CH2), 70.98 (s, crown-CH2), 107.95 (d, J = 
13.0 Hz, CAr), 115.72 (s, CAr), 126.94 (s, CAr), 140.80 (d, J = 34.2 Hz, CAr), 153.68 (s, CAr), 
166.26 (d, J = 10.9 Hz, CAr). 31P{1H} NMR (162 MHz, C6D6): δ 197.65 (s). Anal. Calcd for 
C23H39O5NPNiCl: C, 51.67; H, 7.35; N, 2.62. Found: C, 51.79; H, 7.22; N, 2.55. 
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Figure 4.7 1H NMR spectrum (600 MHz) of (κ3-15c5NCOPiPr)Ni(Cl) (5-Cl) in C6D6. 
 




Figure 4.9 13C{1H} NMR spectrum (151 MHz) of (κ3-15c5NCOPiPr)Ni(Cl) (5-Cl) in C6D6. 
 
Synthesis of (15c5NCOPiPr)Ni(I) 
In a glovebox, a vial was charged with 117.0 mg (0.202 mmol) of (15c5NCOPiPr)Ni(Br), 
148.7 mg (0.896 mmol) of KI, and 8 mL of acetone. The solution was allowed to stir for 5 days 
and then evaporated to dryness yielding a yellow oil. The resulting oil was extracted with 
benzene, filtered, and pumped to dryness. The crude product was recrystallized by layering a 
saturated toluene solution with pentane and placing in a -30 ˚C freezer. The mother liquor was 
decanted after 48 hours and the isolated yellow crystals were washed with pentane (88.5 mg, 
70.0% yield). 1H NMR (600 MHz, C6D6): 1.16 (dd, J = 14.5, 7.0 Hz, 6H, CH(CH3)2), 1.50 (dd, J 
= 17.3, 7.2 Hz, 6H, CH(CH3)2), 2.32 (m, 2H, CH(CH3)2), 3.26 (m, 12H, crown-CH2), 3.74 (m, 
2H, crown-CH2), 3.95 (m, 2H, crown-CH2), 4.06 (m, 4H, crown-CH2), 4.52 (s, 2H, ArCH2N), 
6.53 (d, J = 7.4 Hz, 1H, ArH), 6.67 (d, J = 7.8 Hz, 1H, ArH), 6.92 (t, J = 7.7 Hz, 1H, ArH). 
13C{1H} NMR (151 MHz, C6D6): δ 16.94 (s, CH(CH3)2), 18.89 (d, J = 3.0 Hz, CH(CH3)2), 29.26 
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(d, J = 25.7 Hz, CH(CH3)2), 57.69 (s, crown-CH2), 64.76 (s, ArCH2N), 69.95 (s, crown-CH2), 
70.44 (s, crown-CH2), 70.74 (s, crown-CH2), 107.75 (d, J = 13.1 Hz, CAr), 115.70 (s, CAr), 
127.05 (s, CAr), 145.41 (d, J = 31.6 Hz, CAr), 153.73 (s, CAr), 165.21 (d, J = 10.8 Hz, CAr). 
31P{1H} NMR (243 MHz, C6D6): δ 203.81 (s). Anal. Calcd for C23H39O5NPNiI: C, 44.12; H, 
6.28; N, 2.24. Found: C, 44.32; H, 6.09; N, 2.18. 
 
Figure 4.10 1H NMR spectrum (600 MHz) of (κ3-15c5NCOPiPr)Ni(I) (5-I) in C6D6. 
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Figure 4.11 31P{1H} NMR spectrum (243 MHz) of (κ3-15c5NCOPiPr)Ni(I) (5-I) in C6D6. 
 
Figure 4.12 13C{1H} NMR spectrum (151 MHz) of (κ3-15c5NCOPiPr)Ni(I) (5-I) in C6D6. 
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Synthesis of (15c5NCOPiPr)Pd(Cl) 
A 5 mL solution of (15c5NCOPiPr)H in toluene was slowly added dropwise to a stirring 
suspension of Pd(COD)Cl2 in 5 mL toluene in a 50 mL Schlenk flask. The resulting solution was 
refluxed for 2 hours and then the solvent was removed in vacuo yielding an off-white oil. The oil 
was extracted into as little toluene as possible, filtered, layered with pentane, and placed in a -30 
˚C freezer. The mother liquor was decanted after 48 hours and the isolated white crystals were 
washed with pentane yielding analytically pure product. 1H NMR (600 MHz, C6D6): δ 1.08 (dd, 
J = 15.8, 7.0 Hz, 6H, CH(CH3)2), 1.33 (dd, J = 18.9, 7.2 Hz, 6H, CH(CH3)2), 2.10 (m, 2H, 
CH(CH3)2), 3.33 (m, 8H, crown-CH2), 3.43 (m, 4H, crown-CH2), 3.54 (m, 2H, crown-CH2), 3.66 
(m, 2H, crown-CH2), 3.93 (m, 2H, crown-CH2), 4.22 (m, 2H, crown-CH2), 4.29 (s, 2H, 
ArCH2N), 6.58 (d, J = 7.5 Hz, 1H, ArH), 6.72 (d, J = 7.9 Hz, 1H, ArH), 6.87 (td, J = 7.8, 1.0 Hz, 
1H, ArH). 13C{1H} NMR (151 MHz, C6D6): δ 16.84 (s, CH(CH3)2), 17.54 (d, J = 5.8 Hz, 
CH(CH3)2), 29.26 (d, J = 25.3 Hz, CH(CH3)2), 58.32 (s, crown-CH2), 67.89 (s, ArCH2N), 69.44 
(s, crown-CH2), 70.70 (s, crown-CH2), 70.89 (s, crown-CH2), 108.76 (d, J = 15.8 Hz, CAr), 
117.11 (s, CAr), 126.61 (s, CAr), 145.60 (s, CAr), 151.36 (s, CAr), 163.89 (d, J = 6.6 Hz, CAr). 
31P{1H} NMR (243 MHz, C6D6): δ 201.05 (s).  
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Figure 4.13 1H NMR spectrum (600 MHz) of (κ3-15c5NCOPiPr)Pd(Cl) (6) in C6D6. 
 
Figure 4.14 31P{1H} NMR spectrum (243 MHz) of (κ3-15c5NCOPiPr)Pd(Cl) (6) in C6D6. 
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Figure 4.15 13C{1H} NMR spectrum (151 MHz) of (κ3-15c5NCOPiPr)Pd(Cl) (6) in C6D6. 
 
Table 4.1 Crystal data and structure refinement for (15c5NCOPiPr)Pd(Cl) (6). 
 
Empirical formula  C23H39NO5PClPd  
Formula weight  582.41  
Temperature/K  100.15  
Crystal system  tetragonal  
Space group  P42/n  
a/Å  25.0868(9)  
b/Å  25.0868(9)  
c/Å  8.0944(3)  
α/°  90  
β/°  90  
γ/°  90  
Volume/Å3  5094.2(3)  
Z  8  
ρcalcg/cm3  1.5187  
µ/mm-1  7.712  
F(000)  2428.8  
Crystal size/mm3  0.255 × 0.057 × 0.056  
Radiation  Cu Kα (λ = 1.54178)  
2Θ range for data collection/°  4.98 to 139.98  
Index ranges  -30 ≤ h ≤ 30, -29 ≤ k ≤ 30, -9 ≤ l ≤ 9  
Reflections collected  45168  
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Independent reflections  4829 [Rint = 0.0379, Rsigma = 0.0204]  
Data/restraints/parameters  4829/0/293  
Goodness-of-fit on F2  1.038  
Final R indexes [I>=2σ (I)]  R1 = 0.0224, wR2 = 0.0530  
Final R indexes [all data]  R1 = 0.0261, wR2 = 0.0547  
Largest diff. peak/hole / e Å-3  0.42/-0.49  
 
 
Synthesis of (15c5NCOPiPr)Pt(Cl) 
A 3 mL solution of (15c5NCOPiPr)H in toluene was slowly added dropwise to a stirring 
suspension of Pt(SMe2)2Cl2 in 3 mL toluene in a 25 mL Schlenk flask. The resulting solution 
was refluxed for 5 hours and then the solvent was removed in vacuo yielding an off-white oil. 
The oil was extracted into as little toluene as possible, filtered, layered with pentane, and placed 
in a -30 ˚C freezer. The mother liquor was decanted after 48 hours and the isolated white crystals 
were washed with pentane yielding analytically pure X. 1H NMR (500 MHz, C6D6): δ 1.07 (dd, 
J = 15.9, 7.0 Hz, 6H, CH(CH3)2), 1.28 (dd, J = 18.7, 7.2 Hz, 6H, CH(CH3)2), 2.15 (m, 2H, 
CH(CH3)2), 3.32 (m, 12H, crown-CH2), 3.61 (m, 2H, crown-CH2), 3.86 (m, 4H, crown-CH2), 
4.17 (m, 2H, crown-CH2), 4.44 (s, 2H, ArCH2N), 6.61 (d, J = 7.5 Hz, 1H, ArH), 6.78 (d, J = 7.9 
Hz, 1H, ArH), 6.92 (t, J = 7.7 Hz, 1H, ArH). 13C{1H} NMR (151 MHz, C6D6): δ 16.78 (s, 
CH(CH3)2), 17.15 (d, J = 4.3 Hz, CH(CH3)2), 29.25 (d, J = 37.3 Hz, CH(CH3)2), 58.98 (d, J = 3.0 
Hz, crown-CH2), 68.87 (s, crown-CH2), 69.63 (d, J = 2.7 Hz, ArCH2N), 70.69 (s, crown-CH2), 
70.86 (s, crown-CH2), 70.93 (s, crown-CH2), 108.47 (d, J = 12.6 Hz, CAr), 116.50 (s, CAr), 
125.42 (s, CAr), 136.30 (d, J = 5.3 Hz, CAr), 148.63 (s, CAr), 162.81 (d, J = 3.5 Hz, CAr). 31P{1H} 
NMR (202 MHz, C6D6): δ 159.41 (s).  
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Figure 4.16 1H NMR spectrum (500 MHz) of (κ3-15c5NCOPiPr)Pt(Cl) (7) in C6D6. 
 
Figure 4.17 31P{1H} NMR spectrum (202 MHz) of (κ3-15c5NCOPiPr)Pt(Cl) (7) in C6D6. 
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Figure 4.18 13C{1H} NMR spectrum (151 MHz) of (κ3-15c5NCOPiPr)Pt(Cl) (7) in C6D6. 
 
Table 4.2 Crystal data and structure refinement for (15c5NCOPiPr)Pt(Cl) (6). 
 
Empirical formula  C23H39ClNO5PPt  
Formula weight  671.06  
Temperature/K  100  
Crystal system  tetragonal  
Space group  P42/n  
a/Å  25.1113(8)  
b/Å  25.1113(8)  
c/Å  8.0671(3)  
α/°  90  
β/°  90  
γ/°  90  
Volume/Å3  5086.9(4)  
Z  8  
ρcalcg/cm3  1.752  
µ/mm-1  12.158  
F(000)  2672.0  
Crystal size/mm3  0.282 × 0.113 × 0.094  
Radiation  CuKα (λ = 1.54178)  
2Θ range for data collection/°  7.04 to 140.122  
Index ranges  -30 ≤ h ≤ 29, -30 ≤ k ≤ 29, -9 ≤ l ≤ 9  
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Reflections collected  51263  
Independent reflections  4830 [Rint = 0.0283, Rsigma = 0.0125]  
Data/restraints/parameters  4830/0/293  
Goodness-of-fit on F2  1.223  
Final R indexes [I>=2σ (I)]  R1 = 0.0219, wR2 = 0.0477  
Final R indexes [all data]  R1 = 0.0222, wR2 = 0.0479  
Largest diff. peak/hole / e Å-3  0.55/-0.78  
 
Determining binding affinity by competition with organic macrocycles 
 The calibrated competitive method for determining binding constants by NMR 
spectroscopy reported by Heath et al. was used to determine binding affinities of 1 and 2 via 
competition with 15-crown-5 and 18-crown-6 (1 only). Calibration curves were constructed for 
15-crown-5 and LiOTf and NaBArF4 in CD3CN. A Calibration curve was constructed with 18-
crown-6 and NaBArF4 in CD3CN (18-crown-6 does not exhibit a linear response to [Li+] due to a 
lower binding affinity). The reference value (Kref) used for Li+ complexation by 15-crown-5 was 
log Kref = 4.96. The Kref used for Na+ complexation by 15-crown-5 was log Kref = 5.1. The Kref 
used for Na+ complexation by 18-crown-6 was log Kref = 4.6. 
 Triplicate samples of each reference/(pre)ligand/salt combination were prepared and 
analyzed as follows. A 60 mM stock solution of a reference molecule (15-crown-5 or 18-crown-
6), A 60 mM stock solution of a (pre)ligand (1 or 2), and a 24 mM stock solution of salt (LiOTf 
or NaBArF4) was prepared in CD3CN. 100 µL aliquots of the reference and (pre)ligand stock 
solutions and 250 µL aliquots of the salt solution were combined in a 4 mL glass vial. The 
samples were diluted to 600 µL with CD3CN, transferred to NMR tubes, and analyzed by 1H 
NMR spectroscopy at 25 ± 1 °C. The resulting concentrations of all three species in each sample 
were 10 mM.  
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Figure 4.19 Calibration curves for binding of LiOTf and NaBArF4 by15-crown-5. 
 














  y = 8.04x +3.57
  R2 = 0.99978
 NaBArF4 + 15-crown-5
  y = 5.58x + 3.58


















  y = 7.16x + 3.51
  R2 = 0.9988
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General Procedure for Titrations 
 The following general procedure is for titrations with a final analyte concentration of 10 
mM. A 12 mM stock solution of the corresponding analyte [(pre)ligand or pincer-crown ether 
complex] and a 48 mM stock solution of the corresponding alkali metal salt (24 mM for 
NaBArF4) were prepared in CH3CN. 500 µL aliquots (6.0 × 10−3 mmol) of the analyte solution 
were added to ten glass vials. Aliquots of the alkali metal stock solution corresponding to 0.5−12 
equiv (between 3.0 × 10−3 and 72 × 10−3 mmol) of alkali metal salt to analyte were then added to 
the vials containing the analyte. The protio solvent was completely evaporated. The samples 
were then dissolved in 600 µL of CD3CN, transferred to NMR tubes, and analyzed by 1H NMR 
spectroscopy at 25 ± 1 °C. The final concentration of analyte in solution was 10 mM. The final 
concentration of alkali metal in the samples ranged from 0 to 120 mM.  
An effort was made to perform titrations at varying concentrations of analyte, 2.5 mM, 5 
mM, and 10 mM using the same general procedure above. In these cases, the uncertainty is based 
on the standard deviation of Ka values obtained from fitting the binding isotherm data at the three 
different concentrations. In cases where triplicate measurements at the different concentrations 
have not been completed, the estimated uncertainty of each equilibrium constant is 10% or less. 
Titration data 
Conditions: Isotherms were collected at 25 ± 1 °C in CD3CN  
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Figure 4.21 Binding isotherms for the titration of m-(Aza-15-crown-5)methylphenol (1) with 
LiOTf. 
 




























Figure 4.23 Binding isotherms for the titration of (15c5NCOPiPr)H (2) with LiOTf. 
 
 
























































Figure 4.27 Binding isotherms for the titration of (15c5NCOPiPr)Pd(Cl) (6) with LiOTf. 
 
 































Figure 4.30 Binding isotherms for the titration of [(k3-15c5NCOPiPr)Ir(H)(CO)(NCCH3)][BArF4] 
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